<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">LXmnSjVRS7Qhr53RxVWMcbq</article-id>
      <article-id pub-id-type="other">00016</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2009001200016</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(09)09300616</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2009001200016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Press&#227;o Arterial em jovens como marcador de risco cardiovascular. Estudo do Rio de Janeiro</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Campana</surname>
            <given-names>Erika Maria Gon&#231;alves</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brand&#227;o</surname>
            <given-names>Andr&#233;a Ara&#250;jo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pozzan</surname>
            <given-names>Roberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fran&#231;a</surname>
            <given-names>Maria de F&#225;tima</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fonseca</surname>
            <given-names>Flavia Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pizzi</surname>
            <given-names>Oswaldo L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Magalh&#227;es</surname>
            <given-names>Maria Eliane Campos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freitas</surname>
            <given-names>Elizabete Viana de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brand&#227;o</surname>
            <given-names>Ayrton Pires</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade do Estado do Rio de Janeiro</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>12</month>
        <year>2009</year>
      </pub-date>
      <volume>93</volume>
      <issue>6</issue>
      <fpage>657</fpage>
      <lpage>665</lpage>
      <history>
        <date date-type="accepted">
          <day>06</day>
          <month>08</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>05</day>
          <month>07</month>
          <year>2009</year>
        </date>
        <date date-type="received">
          <day>14</day>
          <month>11</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: O estudo de vari&#225;veis de risco cardiovascular em popula&#231;&#245;es jovens &#233; fundamental para estrat&#233;gias de preven&#231;&#227;o prim&#225;ria OBJETIVO: Avaliar a press&#227;o arterial (PA), perfil antropom&#233;trico e metab&#243;lico em jovens do Estudo do Rio de Janeiro, acompanhados por 17 anos. M&#201;TODOS: Foram avaliados 115 indiv&#237;duos (64 masculinos) em tr&#234;s momentos (seguimento 212,23&#177;16,0 meses): A1 (12,97&#177;1,48 anos), A2 (21,90&#177;1,71 anos) e A3 (30,65&#177;2,00 anos) e divididos em dois grupos: GN (n=84) com pelo menos duas medidas de PA normais nas tr&#234;s avalia&#231;&#245;es; GH (n=31) com pelo menos duas medidas de PA anormais nas tr&#234;s avalia&#231;&#245;es. Nas tr&#234;s ocasi&#245;es foram obtidos: PA e &#237;ndice de massa corporal (IMC). Em A2 e A3: glicose, triglicer&#237;deos, colesterol total e fra&#231;&#245;es. Em A3 acrescentou-se a circunfer&#234;ncia abdominal (CA). RESULTADOS: 1) As m&#233;dias da PA, IMC e CA (p&lt;0,0001) e as preval&#234;ncias de hipertens&#227;o arterial (HAS) e sobrepeso/obesidade (S/O) (p&lt;0,003) foram maiores no GH nas tr&#234;s avalia&#231;&#245;es; 2) As m&#233;dias de LDL-c e glicemia (p&lt;0,05) em A2 e a preval&#234;ncia de s&#237;ndrome metab&#243;lica (SM) em A3 foram maiores no GH; 3) A associa&#231;&#227;o HAS+S/O foi mais prevalente no GH enquanto a associa&#231;&#227;o PA+IMC normais foi mais prevalente no GN (p&lt;0,0001) nas tr&#234;s avalia&#231;&#245;es; 4) HAS em A1 (RR=5,20 = 5,20; p&lt;0,0007), g&#234;nero masculino (RR=5,26 = 5,26; p&lt;0,0019) e S/O em A1 (RR=3,40 = 3,40; p&lt;0,0278) determinaram aumento de risco para HA na fase adulta jovem (A3). CONCLUS&#195;O: Ap&#243;s 17 anos de acompanhamento, a PA de indiv&#237;duos jovens mostrou rela&#231;&#227;o significativa com as vari&#225;veis de risco cardiovascular e a ocorr&#234;ncia de SM na fase adulta jovem.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>press&#227;o arterial</kwd>
        <kwd>fatores de risco</kwd>
        <kwd>crian&#231;a</kwd>
        <kwd>adolescente</kwd>
        <kwd>Brasil</kwd>
        <kwd>Rio de Janeiro</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>05</day>
        <month>05</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> EPIDEMIOLOGIA </p>
    <p>
      <bold>Press&#227;o Arterial em jovens como marcador de risco cardiovascular. Estudo do Rio de Janeiro</bold>
    </p>
    <p>
      <bold>Erika Maria Gon&#231;alves Campana; Andr&#233;a Ara&#250;jo Brand&#227;o; Roberto Pozzan; Maria de F&#225;tima Fran&#231;a; Flavia Lopes Fonseca; Oswaldo L. Pizzi; Maria Eliane Campos Magalh&#227;es; Elizabete Viana de Freitas; Ayrton Pires Brand&#227;o</bold>
    </p>
    <p>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> O estudo de vari&#225;veis de risco cardiovascular em popula&#231;&#245;es jovens &#233; fundamental para estrat&#233;gias de preven&#231;&#227;o prim&#225;ria </p>
    <p><bold>OBJETIVO: </bold> Avaliar a press&#227;o arterial (PA), perfil antropom&#233;trico e metab&#243;lico em jovens do Estudo do Rio de Janeiro, acompanhados por 17 anos. </p>
    <p><bold>M&#201;TODOS: </bold> Foram avaliados 115 indiv&#237;duos (64 masculinos) em tr&#234;s momentos (seguimento 212,23&#177;16,0 meses): A1 (12,97&#177;1,48 anos), A2 (21,90&#177;1,71 anos) e A3 (30,65&#177;2,00 anos) e divididos em dois grupos: GN (n=84) com pelo menos duas medidas de PA normais nas tr&#234;s avalia&#231;&#245;es; GH (n=31) com pelo menos duas medidas de PA anormais nas tr&#234;s avalia&#231;&#245;es. Nas tr&#234;s ocasi&#245;es foram obtidos: PA e &#237;ndice de massa corporal (IMC). Em A2 e A3: glicose, triglicer&#237;deos, colesterol total e fra&#231;&#245;es. Em A3 acrescentou-se a circunfer&#234;ncia abdominal (CA). </p>
    <p><bold>RESULTADOS: </bold> 1) As m&#233;dias da PA, IMC e CA (p&lt;0,0001) e as preval&#234;ncias de hipertens&#227;o arterial (HAS) e sobrepeso/obesidade (S/O) (p&lt;0,003) foram maiores no GH nas tr&#234;s avalia&#231;&#245;es; 2) As m&#233;dias de LDL-c e glicemia (p&lt;0,05) em A2 e a preval&#234;ncia de s&#237;ndrome metab&#243;lica (SM) em A3 foram maiores no GH; 3) A associa&#231;&#227;o HAS+S/O foi mais prevalente no GH enquanto a associa&#231;&#227;o PA+IMC normais foi mais prevalente no GN (p&lt;0,0001) nas tr&#234;s avalia&#231;&#245;es; 4) HAS em A1 (RR=5,20 = 5,20; p&lt;0,0007), g&#234;nero masculino (RR=5,26 = 5,26; p&lt;0,0019) e S/O em A1 (RR=3,40 = 3,40; p&lt;0,0278) determinaram aumento de risco para HA na fase adulta jovem (A3). </p>
    <p><bold>CONCLUS&#195;O: </bold> Ap&#243;s 17 anos de acompanhamento, a PA de indiv&#237;duos jovens mostrou rela&#231;&#227;o significativa com as vari&#225;veis de risco cardiovascular e a ocorr&#234;ncia de SM na fase adulta jovem. </p>
    <p><bold>Palavras-chave: </bold> press&#227;o arterial, fatores de risco, crian&#231;a, adolescente, Brasil, Rio de Janeiro.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A doen&#231;a cardiovascular (DCV) &#233; a principal causa de morte no mundo e no Brasil, e responde por cerca de 300 mil mortes/ano<sup>1-4</sup>. Estes n&#250;meros justificam a busca por um conhecimento mais aprofundado dessa doen&#231;a, e de seus fatores de risco (FR), para que possamos ampliar a preven&#231;&#227;o prim&#225;ria em nosso pa&#237;s<sup>5-7</sup>.</p>
    <p>Reconhecidamente, os FR est&#227;o envolvidos em DCV nos adultos, por&#233;m as informa&#231;&#245;es sobre suas implica&#231;&#245;es em jovens ainda s&#227;o limitadas<sup>5-7</sup>. Entretanto, sabe-se que a aterosclerose inicia-se em tenra idade e progride lentamente at&#233; o aparecimento das suas complica&#231;&#245;es<sup>8,9</sup>. O Estudo de Bogalusa demonstrou que les&#245;es ateroscler&#243;ticas estavam presentes em aorta e coron&#225;rias em indiv&#237;duos jovens, e que estas les&#245;es estavam relacionadas &#224; presen&#231;a de FR<sup>5-7</sup>.</p>
    <p>Entender o comportamento dos FR ao longo dos anos &#233; de fundamental import&#226;ncia, pois eles tendem a se repetir e se agravar - <italic>"Fen&#244;meno de Trilha ou Tracking"</italic><sup>5-7,10-16</sup> - e determinam altera&#231;&#245;es progressivas no aparelho cardiovascular<sup>5-7,8,9,10-16</sup>.</p>
    <p>No Brasil, os resultados do Estudo do Rio de Janeiro (ERJ) t&#234;m demonstrado que a medida elevada da press&#227;o arterial (PA) na inf&#226;ncia e adolesc&#234;ncia associou-se a maiores valores de PA, dos &#237;ndices antropom&#233;tricos e maior preval&#234;ncia de s&#237;ndrome metab&#243;lica (SM) na fase adulta jovem<sup>12-16</sup>.</p>
    <p>Todos esses achados demonstram de forma inequ&#237;voca a associa&#231;&#227;o entre os FR e a doen&#231;a ateroscler&#243;tica nas fases iniciais da vida<sup>17</sup>. No entanto, o caminho que leva &#224; transi&#231;&#227;o do risco cardiovascular aumentado na inf&#226;ncia e &#224; DCV no adulto ainda n&#227;o est&#225; completamente estabelecido<sup>18</sup>.</p>
    <p>O presente estudo tem por objetivo avaliar a PA, o perfil antropom&#233;trico e as vari&#225;veis metab&#243;licas em indiv&#237;duos jovens, estratificados pelo comportamento da sua PA obtida em tr&#234;s ocasi&#245;es, por 17 anos de acompanhamento, desde a inf&#226;ncia e a adolesc&#234;ncia.</p>
    <p>
      <bold>Metodologia</bold>
    </p>
    <p>A popula&#231;&#227;o deste estudo origina-se do Estudo do Rio de Janeiro<sup>12-16</sup>, uma linha de pesquisa sobre PA e outros FR cardiovascular em jovens e suas fam&#237;lias, que vem sendo desenvolvida na Universidade do Estado do Rio de Janeiro, desde 1983. Este Estudo foi realizado em duas etapas: na primeira, foram avaliadas cerca de 3 mil crian&#231;as entre 6 anos e 9 anos de idade (1983-1986) em duas fases: escolar e domiciliar, para determina&#231;&#227;o das curvas de normalidade da PA por sexo e faixa et&#225;ria. A partir de 1987, iniciou-se a segunda etapa do ERJ, sendo avaliadas crian&#231;as e adolescentes entre 10 anos e 15 anos de idade e que v&#234;m sendo acompanhadas ao longo de cinco fases de avalia&#231;&#227;o: escolar (1987-1988), domiciliar (1989-1991), hospitalar (1992-1995), familiar (1996-1999) e ambulatorial (2004-2008). Nesta &#250;ltima, se insere o presente estudo (<xref ref-type="fig" rid="f1">Figura 1</xref>). Em A1 foram examinados 3.900 crian&#231;as e adolescentes para a determina&#231;&#227;o das curvas de normalidade da PA por sexo e faixa et&#225;ria. Em A2, foram estudados dois grupos de indiv&#237;duos, estratificados pela PA obtida em A1: o grupo com PA aumentada, definida por uma PA<underline>&gt;</underline>p95, e o grupo com PA normal, definida por uma PA<underline>&lt;</underline>p50. Estes dois grupos reuniram uma amostra de 385 alunos-alvo que foram estudados e acompanhados nas fases subsequentes do ERJ. Dessa forma, os 115 alunos-alvo que participaram de A3 s&#227;o representativos dos 385 participantes em A2, entretanto n&#227;o s&#227;o representativos dos 3.900 jovens avaliados na fase escolar da segunda etapa do ERJ, em decorr&#234;ncia do desenho do estudo descrito anteriormente.</p>
    <fig id="f1">
      <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf01.jpg"/></fig>
    <p>Foram avaliados 115 indiv&#237;duos (64M), designados como alunos-alvo, de ambos os sexos, em seguimento de 212,23&#177;16,0 meses. Para este estudo foram consideradas tr&#234;s avalia&#231;&#245;es da segunda etapa do ERJ, a saber: A1 (Fase Escolar): aos 12,97&#177;1,48 anos (10-16 anos), A2 (Fase Familiar): aos 21,90&#177;1,71 anos (18-26 anos) e A3 (Fase Ambulatorial): aos 30,65&#177;2,00 anos (27-36 anos).</p>
    <p>Dois grupos foram constitu&#237;dos de acordo com o comportamento da PA, a saber: grupo N (pelo menos duas medidas de PA normais nas tr&#234;s avalia&#231;&#245;es) com 84 (42 masculinos) indiv&#237;duos e grupo H (pelo menos duas medidas de PA anormais nas tr&#234;s avalia&#231;&#245;es) com 31(22 masculinos) indiv&#237;duos (<xref ref-type="fig" rid="f2">Figura 2</xref>).</p>
    <p content-type="asset">
      <fig id="f2">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf02.jpg"/></fig>
    </p>
    <p>Este estudo foi aprovado pelo Comit&#234; de &#201;tica em Pesquisa do HUPE. Todos os indiv&#237;duos assinaram o termo de consentimento livre e esclarecido.</p>
    <p>Nas tr&#234;s avalia&#231;&#245;es, aplicou-se um question&#225;rio para a an&#225;lise das vari&#225;veis cl&#237;nicas, epidemiol&#243;gicas e socioculturais, foram obtidos PA, peso (P) e altura (A) e calculado o IMC. Em A2 e A3 foram dosados, ap&#243;s jejum de 12h, glicose, colesterol, HDL-c, triglicer&#237;deos e calculado o LDL-c. Ainda em A2 a dosagem de insulina e o calculo do HOMA-IR foram realizados. Em A3, foi acrescentada a medida da circunfer&#234;ncia abdominal (CA).</p>
    <p>A PA foi medida no membro superior direito, com o indiv&#237;duo deitado, utilizando-se esfigmoman&#244;metro de coluna de merc&#250;rio, com manguitos apropriados para o bra&#231;o dos indiv&#237;duos<sup>19</sup>. Foram realizados tr&#234;s registros da PA, com intervalos de 5 minutos entre cada medida, sendo o &#250;ltimo deles utilizado para a an&#225;lise. Foi considerada HAS em A1 quando a PA foi <underline>&gt;</underline>percentil 95 para sexo e idade e em A2 e A3, quando a PA <underline>&gt;</underline>140/90mmHg.</p>
    <p>O IMC foi obtido por meio do quociente: IMC=P/A<sup>2</sup>. Foi considerado peso normal quando os valores do IMC foram &lt;25kg/m&#178;; sobrepeso quando os valores do IMC situaram-se entre 25kg/m&#178; e 29,99kg/m<sup>2</sup>; e obesidade quando os valores do IMC foram <underline>&gt;</underline>30kg/m<sup>20</sup>.</p>
    <p>A circunfer&#234;ncia abdominal foi medida por meio de fita m&#233;trica inextens&#237;vel, com precis&#227;o de 0,1cm, no ponto m&#233;dio entre a crista il&#237;aca e a borda inferior da &#250;ltima costela<sup>21</sup>. Foram definidos como valores aumentados, a CA &gt;102cm para homens e &gt;88cm para mulheres<sup>22,23</sup>.</p>
    <p>A presen&#231;a de s&#237;ndrome metab&#243;lica foi definida de acordo com a I Diretriz Brasileira de SM, adotando-se o ponto de corte para glicemia de jejum &gt;=100mg/dl, proposto por Grundy e cols.<sup>22,24</sup>.</p>
    <p>Para as vari&#225;veis metab&#243;licas, foi considerado valor normal, quando a glicemia era &lt;100mg/dl; faixa de intoler&#226;ncia &#224; glicose quando a glicemia se situava entre 100mg/dl e 126mg/dl e DM quando glicemia era <underline>&gt;</underline>126mg/d<sup>25</sup>. Os valores de normalidade para o perfil lip&#237;dico seguiram as recomenda&#231;&#245;es da IV Diretriz Brasileira Sobre Dislipidemias e Preven&#231;&#227;o da Aterosclerose<sup>26</sup>.</p>
    <p>As informa&#231;&#245;es colhidas foram armazenadas em um &#250;nico banco de dados atrav&#233;s do programa Microsoft Access. Os dados foram analisados atrav&#233;s do programa estat&#237;stico <italic>SPSS for Windows</italic>, vers&#227;o 8.0.0, Copyright SPSS Inc. 1989 - 1997.</p>
    <p>Foram utilizados os seguintes testes estat&#237;sticos:</p>
    <p>&#149; Teste t de Student (t): utilizado para compara&#231;&#227;o de duas s&#233;ries de dados quando respeitadas as seguintes condi&#231;&#245;es: a m&#233;dia e o desvio padr&#227;o s&#227;o boas estimativas da tend&#234;ncia central e da dispers&#227;o desses conjuntos; as amostras s&#227;o normalmente distribu&#237;das; as popula&#231;&#245;es de onde os dados foram retirados t&#234;m vari&#226;ncias similares e o n&#250;mero de observa&#231;&#245;es &#233; igual para os dois grupos.</p>
    <p>&#149; Teste do Qui-quadrado (&#967;<sup>2</sup>): utilizado para a compara&#231;&#227;o das distribui&#231;&#245;es de frequ&#234;ncia das vari&#225;veis categ&#243;ricas de amostras independentes.</p>
    <p>&#149; O modelo de regress&#227;o n&#227;o linear log&#237;stico &#233; utilizado quando a vari&#225;vel resposta &#233; qualitativa com dois resultados poss&#237;veis (dicot&#244;mica).</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>As caracter&#237;sticas gerais dos 115 alunos-alvo estudados e dos dois grupos constitu&#237;dos com base no comportamento da PA ao longo de 17 anos de acompanhamento (GN=Normal e GH=Hipertenso) est&#227;o apresentadas na <xref ref-type="table" rid="t1">Tabela 1</xref>.</p>
    <p content-type="asset">
      <table-wrap id="t1">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt01.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Press&#227;o Arterial Sist&#243;lica e Diast&#243;lica</bold>
    </p>
    <p>Na <xref ref-type="table" rid="t2">Tabela 2</xref> est&#227;o expostas as m&#233;dias da press&#227;o arterial sist&#243;lica (PAS) e diast&#243;lica (PAD) na popula&#231;&#227;o total e nos grupos nos tr&#234;s momentos de avalia&#231;&#227;o A1, A2 e A3. Comparando-se o comportamento da PA entre os grupos N (GN) e H (GH), observa-se que as m&#233;dias da PAS e da PAD foram maiores no GH do que no GN com diferen&#231;as estatisticamente significativas nas tr&#234;s avalia&#231;&#245;es.</p>
    <p content-type="asset">
      <table-wrap id="t2">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt02.jpg"/></table-wrap>
    </p>
    <p>Analisando-se a varia&#231;&#227;o positiva da PA ao final de 9 anos (A1&#8594; A2), n&#227;o foram observadas diferen&#231;as estatisticamente significativas para a varia&#231;&#227;o tanto da PAS quanto da PAD entre os GN e GH. Ao final de 17 anos (A1&#8594; A3), observou-se uma maior varia&#231;&#227;o positiva da PAD no GH (p=0,024); o mesmo n&#227;o foi observado para a PAS.</p>
    <p>As preval&#234;ncias de HAS, foram de 39,10%, 23,50% e 30,40%, em A1, A2 e A3 respectivamente. Nas tr&#234;s avalia&#231;&#245;es o GH apresentou maior preval&#234;ncia de HA do que o GN (p &lt; 0,0001).</p>
    <p>
      <bold>Vari&#225;veis Antropom&#233;tricas</bold>
    </p>
    <p>As vari&#225;veis antropom&#233;tricas podem ser observadas na <xref ref-type="table" rid="t3">Tabela 3</xref>.</p>
    <p content-type="asset">
      <table-wrap id="t3">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt03.jpg"/></table-wrap>
    </p>
    <p>Foram observadas maiores m&#233;dias de peso e IMC no GH, com diferen&#231;as significativas nas tr&#234;s avalia&#231;&#245;es. O mesmo comportamento foi observado para a CA obtida em A3.</p>
    <p>A preval&#234;ncia de sobrepeso/obesidade (S/O) na popula&#231;&#227;o foi de 25,20%, 30,40% e 53,9% em A1, A2 e A3, respectivamente. O GH apresentou maior preval&#234;ncia de S/O do que o GN nas tr&#234;s avalia&#231;&#245;es (p &lt; 0,003).</p>
    <p>A preval&#234;ncia de CA aumentada em A3 foi de 38,30% na popula&#231;&#227;o total, com 71,00% no grupo H e 26,20% no grupo N (p &lt; 0,0001).</p>
    <p>
      <bold>Vari&#225;veis Metab&#243;licas e S&#237;ndrome Metab&#243;lica</bold>
    </p>
    <p>As vari&#225;veis metab&#243;licas obtidas em A2 e A3 est&#227;o na <xref ref-type="table" rid="t4">Tabela 4</xref>.</p>
    <p content-type="asset">
      <table-wrap id="t4">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt04.jpg"/></table-wrap>
    </p>
    <p>Quando se comparou o comportamento dos grupos em A2 e A3, foi observado que o GH apresentou um perfil metabolicamente mais desfavor&#225;vel (maiores m&#233;dias de Col T, LDL-c, TGL, G e insulinemia, e menores m&#233;dias de HDL-c) quando comparado com o GN, embora tenham sido observadas diferen&#231;as estatisticamente significativas apenas para o LDL-c e a glicemia em A2.</p>
    <p>As altera&#231;&#245;es metab&#243;licas que comp&#245;em um perfil de risco desfavor&#225;vel (HDL-c baixo, insulinemia aumentada, intoler&#226;ncia &#224; glicose - definida como HOMA-IR &gt;percentil 95 para sexo e idade em A2, ou como glicemia de jejum &gt;100 e &lt; 126mg/dl em A3) bem como a s&#237;ndrome metab&#243;lica, foram mais prevalentes no GH (<xref ref-type="table" rid="t5">Tabela 5</xref>).</p>
    <p content-type="asset">
      <table-wrap id="t5">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt05.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Comportamento da PA e do IMC Associados</bold>
    </p>
    <p>Considerando-se a presen&#231;a ou aus&#234;ncia de PA aumentada e a presen&#231;a ou aus&#234;ncia de S/O, nas tr&#234;s avalia&#231;&#245;es (A1, A2 e A3), foi observada a combina&#231;&#227;o dessas duas condi&#231;&#245;es em quatro modelos: [PA normal + IMC normal]; [PA normal + IMC elevado]; [PA elevada + IMC normal] e [PA elevada + IMC elevado]. Observou-se que o modelo de associa&#231;&#227;o mais desfavor&#225;vel [PA elevada + IMC elevado] apresentou maior preval&#234;ncia no GH nos tr&#234;s momentos de avalia&#231;&#227;o. De maneira inversa, para o modelo de associa&#231;&#227;o normal [PA normal + IMC normal] observou-se maior preval&#234;ncia no GN nos tr&#234;s momentos de avalia&#231;&#227;o. As preval&#234;ncias dos quatro modelos de associa&#231;&#227;o em A1, A2 e A3 est&#227;o representadas na <xref ref-type="fig" rid="f3">Figura 3</xref>.</p>
    <p content-type="asset">
      <fig id="f3">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf03.jpg"/></fig>
    </p>
    <p>
      <bold>An&#225;lise de Regress&#227;o Log&#237;stica</bold>
    </p>
    <p>Para a an&#225;lise do risco relativo, foi constru&#237;do um modelo de regress&#227;o log&#237;stica onde a vari&#225;vel dependente utilizada foi a HAS em A3 e as vari&#225;veis independentes analisadas foram a presen&#231;a ou aus&#234;ncia de HAS em A1, o g&#234;nero e a presen&#231;a ou aus&#234;ncia de S/O em A1.</p>
    <p>Observou-se que a presen&#231;a de HAS em A1 (RR: 5,20; p &lt; 0,0007), o g&#234;nero masculino (RR: 5,26; p &lt; 0,0019) e a presen&#231;a de S/O em A1 (RR: 3,40; p &lt; 0,0278) determinaram um aumento de risco para ocorr&#234;ncia de HAS em A3.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Estudar o comportamento dos FR cardiovascular desde a inf&#226;ncia e adolesc&#234;ncia at&#233; a fase adulta &#233; de fundamental import&#226;ncia para a ado&#231;&#227;o de medidas de preven&#231;&#227;o prim&#225;ria<sup>5-7,17,27-29</sup>.</p>
    <p>O comportamento da PA tem sido analisado em v&#225;rias popula&#231;&#245;es de jovens e existem cada vez mais ind&#237;cios de que a PA na inf&#226;ncia se correlaciona com a PA na idade adulta e de que a HAS nas crian&#231;as &#233; um importante FR para o desenvolvimento futuro de DAC<sup>27-32</sup>. No presente estudo, a repeti&#231;&#227;o de valores normais e anormais da PA a partir da inf&#226;ncia e da adolesc&#234;ncia permitiu separar dois grupos de indiv&#237;duos jovens que apresentam as vari&#225;veis que comp&#245;em os FR cardiovascular com comportamentos diferentes, refor&#231;ando a import&#226;ncia de se observar estas vari&#225;veis desde faixas et&#225;rias mais precoces.</p>
    <p>Sabe-se que a PA tende a aumentar a partir do nascimento, ao longo da inf&#226;ncia e adolesc&#234;ncia<sup>30,31</sup>. Nesta an&#225;lise da coorte do ERJ, foi observado um comportamento semelhante, havendo um incremento progressivo da PA com a idade, verificado pela varia&#231;&#227;o positiva da PAS e da PAD ao longo dos 17 anos de seguimento tanto no GN quanto no GH.</p>
    <p>Os valores de PA observados na inf&#226;ncia tendem a se manter na mesma faixa de percentil ao longo do tempo, o que significa que as crian&#231;as com percentis mais elevados de PA tendem a se manter nos percentis mais elevados at&#233; a idade adulta<sup>17,27,30-32</sup>. Nos tr&#234;s momentos de avalia&#231;&#227;o, as m&#233;dias de PA e as preval&#234;ncias de HAS foram sempre maiores no GH do que no GN, sugerindo que crian&#231;as e adolescentes apresentam um padr&#227;o de comportamento da PA ao longo do tempo. Cabe ressaltar que o desenho original do Estudo do Rio de Janeiro caracterizou-se pelo acompanhamento de indiv&#237;duos jovens com comportamentos distintos da PA na fase escolar: com percentil de PA&gt;=95 e com percentil de PA&lt;=50. Desta forma, em fases subsequentes do estudo, s&#227;o esperadas taxas de preval&#234;ncia de HAS mais elevadas do que as observadas na popula&#231;&#227;o geral desta faixa et&#225;ria jovem.</p>
    <p>A composi&#231;&#227;o corporal &#233; um dos principais determinantes da PA em crian&#231;as. Existe uma rela&#231;&#227;o direta entre o peso e a PA, em especial na segunda d&#233;cada de vida<sup>33-35</sup>. Em nosso pa&#237;s, diversas publica&#231;&#245;es da coorte do ERJ j&#225; apontavam para a import&#226;ncia da composi&#231;&#227;o corporal no determinismo da PA em crian&#231;as e adolescentes<sup>12-16</sup>. No presente estudo, observaram-se m&#233;dias de peso, altura e do IMC maiores no GH nos tr&#234;s momentos de avalia&#231;&#227;o, demonstrando haver tamb&#233;m nesta popula&#231;&#227;o uma associa&#231;&#227;o entre composi&#231;&#227;o corporal e PA. De maneira semelhante ao relatado na literatura<sup>12-16,33-35</sup> observou-se um aumento progressivo das preval&#234;ncias de IMC aumentado ao longo dos 17 anos de acompanhamento (A1 = 25,2% &#8594; A2 = 30,4% &#8594; A3 = 53,9%). Refor&#231;ando o conhecimento da associa&#231;&#227;o entre S/O e HAS nesta faixa et&#225;ria, foi observado que, desde a inf&#226;ncia at&#233; o momento atual, os alunos-alvo pertencentes ao GH apresentaram maiores preval&#234;ncias de S/O.</p>
    <p>Aspecto relevante &#233; conhecer o padr&#227;o de distribui&#231;&#227;o corporal da gordura e sua rela&#231;&#227;o com os FR em popula&#231;&#245;es jovens<sup>34,35</sup>. Na amostra de estudo, a associa&#231;&#227;o entre obesidade central e PA ficou evidente, com maior m&#233;dia de CA em A3 nos indiv&#237;duos do GH.</p>
    <p>Al&#233;m disso, &#233; importante estudar a agrega&#231;&#227;o de HAS e S/O, pelo seu potencial desforavor&#225;vel<sup>11,36-38</sup>. Os resultados do presente estudo v&#227;o de encontro &#224; literatura<sup>36-38</sup>, demonstrando um aumento progressivo na preval&#234;ncia da associa&#231;&#227;o [HAS + S/O] ao longo dos 17 anos de acompanhamento (A1 = 15,7% &#8594; A3 = 27%). Se for considerada a condi&#231;&#227;o de pelo menos um dos fatores presentes (HAS ou S/O) observa-se que este perfil desfavor&#225;vel de risco tamb&#233;m se tornou mais prevalente ao longo do acompanhamento estando presente em quase 60% (57,5%) dos alunos-alvo na fase atual (A3).</p>
    <p>No presente estudo, os indiv&#237;duos pertencentes ao GH apresentaram um perfil metab&#243;lico mais desfavor&#225;vel do que os indiv&#237;duos do GN, com maiores m&#233;dias de Col T, LDL-c, TGL e menores m&#233;dias de HDL-c. Nos indiv&#237;duos pertencentes ao GH, a preval&#234;ncia de valores baixos de HDL-c foi quase o dobro dos indiv&#237;duos do GN, o que refor&#231;a o perfil de risco CV desfavor&#225;vel nesse grupo de jovens.</p>
    <p>A agrega&#231;&#227;o de FR em adultos &#233; bastante comum na pr&#225;tica cl&#237;nica. Nos &#250;ltimos anos esta mesma associa&#231;&#227;o vem sendo documentada na popula&#231;&#227;o jovem<sup>12-16,22,24,37</sup>. A s&#237;ndrome metab&#243;lica (SM), importante representante da agrega&#231;&#227;o de FR, &#233; uma condi&#231;&#227;o associada a altas morbidade e mortalidade cardiovasculares e ao elevado custo socioecon&#244;mico<sup>12,14-16,22,37</sup>.</p>
    <p>Na popula&#231;&#227;o estudada, observou-se um perfil metabolicamente mais desfavor&#225;vel nos alunos-alvo que pertenciam ao GH. Assim como observado na literatura<sup>39,40</sup>, o HDL-c baixo foi uma altera&#231;&#227;o altamente prevalente (61,3%) nesta popula&#231;&#227;o. Outros elementos que fazem parte do contexto da SM e refletem a altera&#231;&#227;o da toler&#226;ncia &#224; glicose e resist&#234;ncia insul&#237;nica (HOMA-IR, glicemia de jejum anormal e n&#237;veis de insulina s&#233;rica elevados tamb&#233;m foram mais prevalentes nos indiv&#237;duos pertencentes ao GH, de forma concordante com a literatura<sup>12,16,39,40</sup>. A preval&#234;ncia de SM apresentou distribui&#231;&#227;o semelhante sendo mais prevalente entre os alunos-alvo do GH.</p>
    <p>Cabe considerar ainda o impacto de alguns FR modific&#225;veis e n&#227;o modific&#225;veis no aumento do risco de desenvolvimento das DCV. No conjunto de FR n&#227;o modific&#225;veis a idade e o g&#234;nero s&#227;o reconhecidamente importantes no determinismo da DCV. O g&#234;nero masculino est&#225; associado a maior risco cardiovascular<sup>8,11,17,26,27</sup>. Na an&#225;lise de regress&#227;o log&#237;stica os principais fatores relacionados &#224; ocorr&#234;ncia de HAS na idade adulta jovem foram: o g&#234;nero masculino (5,26; IC 95% 1,8438 - 15,0353; p = 0,0019), a presen&#231;a de HAS (5,20; IC 95% 1,9986 - 13,5061; p = 0,007) e a presen&#231;a de S/O (3,40 IC95% 1,1430 - 10,1046; p = 0,0278) na inf&#226;ncia e adolesc&#234;ncia (A1), ressaltando que, al&#233;m do g&#234;nero masculino, a presen&#231;a de HAS e S/O em A1 s&#227;o importantes para o perfil de risco cardiovascular na fase adulta jovem.</p>
    <p>A principal limita&#231;&#227;o deste estudo &#233; a mesma experimentada por diversas coortes existentes na literatura e relaciona-se ao car&#225;ter longitudinal do seguimento que determina perdas progressivas de uma parte da amostra original. Entretanto, destaca-se que a amostra populacional do Estudo do Rio de Janeiro &#233; uma amostra n&#227;o hospitalar e que vem sendo seguida nos &#250;ltimos 17 anos, constituindo-se na coorte brasileira desta faixa et&#225;ria com mais longo seguimento at&#233; os dias atuais.</p>
    <p>Em conclus&#227;o, a manuten&#231;&#227;o de n&#237;veis elevados de press&#227;o arterial desde a inf&#226;ncia at&#233; a idade adulta jovem correlacionou-se com um perfil de risco cardiovascular mais desfavor&#225;vel representado por maiores preval&#234;ncias de hipertens&#227;o arterial, sobrepeso/obesidade, altera&#231;&#245;es lip&#237;dicas e glic&#237;dicas e a presen&#231;a de s&#237;ndrome metab&#243;lica na fase adulta jovem. Os achados sugerem que medidas de preven&#231;&#227;o prim&#225;ria dos fatores de risco cardiovascular devem-se iniciar na inf&#226;ncia e adolesc&#234;ncia.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi parcialmente financiado por Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado do Rio de Janeiro- Faperj.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Erika Maria Gon&#231;alves Campana, pela Universidade do Estado do Rio de Janeiro.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Erika Maria Gon&#231;alves Campana </p>
        <p> Rua S&#227;o Janu&#225;rio, 159 / 1103 B - Fonseca </p>
        <p> 24130386 - Niter&#243;i, RJ - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="erikamaria@cardiol.br">erikamaria@cardiol.br</email>, </p>
        <p>
          <email xlink:href="campanaemg@predialnet.com.br">campanaemg@predialnet.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 14/11/08; revisado recebido em 05/07/09; aceito em 06/08/09.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Minist&#233;rio da Sa&#250;de. Datasus. Informa&#231;&#245;es de sa&#250;de. Estat&#237;sticas vitais - Mortalidade e nascidos vivos. [Acesso em 2008 nov. 02]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://w3.datasus.gov.br/datasus/datasus.php">http://w3.datasus.gov.br/datasus/datasus.php</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Datasus: Informa&#231;&#245;es de sa&#250;de. Estat&#237;sticas vitais - Mortalidade e nascidos vivos</source>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Rivera ARQ,    Carvalho CCF, Arantes MK. Introdu&#231;&#227;o. In: Souza GMR, Piegas LS,    Souza JENR. Prote&#237;na C-reativa e doen&#231;a arterial coron&#225;ria.    Rio de Janeiro: Revinter; 2004. p. 1-4. (S&#233;rie Monografias Dante Pazzanese).</mixed-citation>
        <element-citation publication-type="book">
          <source>Prote&#237;na C-reativa e doen&#231;a arterial coron&#225;ria</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Rivera</surname>
              <given-names>ARQ</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>CCF</given-names>
            </name>
            <name>
              <surname>Arantes</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>GMR</given-names>
            </name>
            <name>
              <surname>Piegas</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>JENR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Balbinotto Neto    G, Silva EM. Os custos da doen&#231;a cardiovascular no Brasil: um breve coment&#225;rio    econ&#244;mico [Editorial]. Arq Bras Cardiol. 2008; 91 (4): 217.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Os custos da doen&#231;a cardiovascular no Brasil: um breve coment&#225;rio econ&#244;mico [Editorial]</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>217</fpage>
          <issue>4</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Balbinotto Neto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Azambuja MIR,    Foppa M, Maranh&#227;o MC, Achutti AC. Impacto econ&#244;mico dos casos de    doen&#231;a cardiovascular grave no Brasil: uma estimativa baseada em dados    secund&#225;rios. Arq Bras Cardiol. 2008; 91 (3): 163-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impacto econ&#244;mico dos casos de doen&#231;a cardiovascular grave no Brasil: uma estimativa baseada em dados secund&#225;rios</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>163</fpage>
          <lpage>71</lpage>
          <issue>3</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Azambuja</surname>
              <given-names>MIR</given-names>
            </name>
            <name>
              <surname>Foppa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maranh&#227;o</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Achutti</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Berenson GS,    Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between    multiple cardiovascular risk factors and atherosclerosis in children and young    adults. The Bogalusa Heart Study. N Eng J Med. 1998; 338: 1650-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: The Bogalusa Heart Study</article-title>
          <source>N Eng J Med</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1650</fpage>
          <lpage>6</lpage>
          <volume>338</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Newman WP</surname>
              <given-names>III</given-names>
            </name>
            <name>
              <surname>Tracy</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Wattigney</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Burke GL, Cresanta    JL, Shear CL, Miner MH, Berenson GS. Cardiovascular risk factors and their modification    in children. Cardiol Clin. 1986; 4(1): 33-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular risk factors and their modification in children</article-title>
          <source>Cardiol Clin</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>33</fpage>
          <lpage>46</lpage>
          <issue>1</issue>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Burke</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Cresanta</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Shear</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Miner</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Berenson GS,    Srnivasan SR. Bogalusa Heart Study Group. Cardiovascular risk factors in young    with implications for aging: the Bogalusa Heart Study. Neurobiol Aging. 2005;    26: 303-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Bogalusa Heart Study Group: Cardiovascular risk factors in young with implications for aging: the Bogalusa Heart Study</article-title>
          <source>Neurobiol Aging</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>303</fpage>
          <lpage>7</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Srnivasan</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Santos MG, Pegoraro    M, Sandrini F, Macuco EC. Fatores de risco no desenvolvimento da aterosclerose    na inf&#226;ncia e adolesc&#234;ncia. Arq Bras Cardiol. 2008; 90 (4): 301-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fatores de risco no desenvolvimento da aterosclerose na inf&#226;ncia e adolesc&#234;ncia</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>301</fpage>
          <lpage>8</lpage>
          <issue>4</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Pegoraro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sandrini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Macuco</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Fran&#231;oso    LA, Coates V. Evid&#234;ncias anatomopatol&#243;gicas do in&#237;cio da    aterosclerose na inf&#226;ncia e adolesc&#234;ncia. Arq Bras Cardiol. 2002;    78 (1): 131-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evid&#234;ncias anatomopatol&#243;gicas do in&#237;cio da aterosclerose na inf&#226;ncia e adolesc&#234;ncia</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>131</fpage>
          <lpage>6</lpage>
          <issue>1</issue>
          <volume>78</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fran&#231;oso</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Coates</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Silva MAM,    Rivera IR, Ferraz MRMT, Pinheiro AJT, Alves SWS, Moura AA, et al. Preval&#234;ncia    de fatores de risco cardiovascular em crian&#231;as e adolescentes da rede    de ensino da cidade de Macei&#243;. Arq Bras Cardiol. 2005; 84 (5): 387-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preval&#234;ncia de fatores de risco cardiovascular em crian&#231;as e adolescentes da rede de ensino da cidade de Macei&#243;</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>387</fpage>
          <lpage>92</lpage>
          <issue>5</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>MAM</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Ferraz</surname>
              <given-names>MRMT</given-names>
            </name>
            <name>
              <surname>Pinheiro</surname>
              <given-names>AJT</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>SWS</given-names>
            </name>
            <name>
              <surname>Moura</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Monego ET,    Jardim PCB. Determinantes de risco para doen&#231;as cardiovasculares em escolares.    Arq Bras Cardiol. 2006; 87 (1): 37-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Determinantes de risco para doen&#231;as cardiovasculares em escolares</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>37</fpage>
          <lpage>45</lpage>
          <issue>1</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Monego</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Jardim</surname>
              <given-names>PCB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Brand&#227;o    AA, Pozzan R, Magalh&#227;es MEC, Brand&#227;o AP. Aggregation of metabolic    abnormalities, overweight and high blood pressure, in young subjects followed-up    for a 10-year-period [Abstract]. The Rio de Janeiro Study. J Am Coll    Cardiol. 2000; 35 (Suppl A): 264A.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aggregation of metabolic abnormalities, overweight and high blood pressure, in young subjects followed-up for a 10-year-period [Abstract]: The Rio de Janeiro Study</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>264A</fpage>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Magalh&#227;es</surname>
              <given-names>MEC</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Brand&#227;o    AP, Brand&#227;o AA, Araujo EMM. The significance of physical development    on blood pressure curve of children between 6 and 9 years of age and its relationship    with familial aggregation. J Hypertens. 1989; 7 (Suppl 1): S37-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The significance of physical development on blood pressure curve of children between 6 and 9 years of age and its relationship with familial aggregation</article-title>
          <source>J Hypertens</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>S37</fpage>
          <lpage>9</lpage>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Araujo</surname>
              <given-names>EMM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Pozzan R, Brand&#227;o    AA, Cerqueira RCO, Brand&#227;o AP. The importance of overweight on the follow-up    of adolescents with different percentiles of blood pressure - The Rio de Janeiro    Study [Abstract]. Hypertension. 1995; 25: 28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The importance of overweight on the follow-up of adolescents with different percentiles of blood pressure - The Rio de Janeiro Study [Abstract]</article-title>
          <source>Hypertension</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>28</fpage>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Cerqueira</surname>
              <given-names>RCO</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Pozzan R, Brand&#227;o    AA, Silva SL, Brand&#227;o AP. Hyperglycemia, hyperinsulinemia, overweight,    and high blood pressure in young adults: the Rio de Janeiro Study. Hypertension.    1997; 30 (3pt2): 650-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hyperglycemia, hyperinsulinemia, overweight, and high blood pressure in young adults: the Rio de Janeiro Study</article-title>
          <source>Hypertension</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>650</fpage>
          <lpage>3</lpage>
          <issue>3</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Magalh&#227;es    MEC, Pozzan R, Brand&#227;o AA, Cerqueira RCO, Roussouli&#232;res ALS, Czwarcwald    C, et al. Early blood pressure level as a mark of familial aggregation of metabolic    cardiovascular risk factors - the Rio de Janeiro Study. J Hypertens. 1998; 16:    1885-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early blood pressure level as a mark of familial aggregation of metabolic cardiovascular risk factors - the Rio de Janeiro Study</article-title>
          <source>J Hypertens</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1885</fpage>
          <lpage>9</lpage>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Magalh&#227;es</surname>
              <given-names>MEC</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Cerqueira</surname>
              <given-names>RCO</given-names>
            </name>
            <name>
              <surname>Roussouli&#232;res</surname>
              <given-names>ALS</given-names>
            </name>
            <name>
              <surname>Czwarcwald</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Brand&#227;o    AA, Magalh&#227;es ME, Pozzan R, Fran&#231;a MF, Pozzan R, Freitas EV, et    al. Hipertens&#227;o arterial no jovem como marcador para a preven&#231;&#227;o    cardiovascular prim&#225;ria. Rev SOCERJ. 2002; 15 (4): 247-55.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hipertens&#227;o arterial no jovem como marcador para a preven&#231;&#227;o cardiovascular prim&#225;ria</article-title>
          <source>Rev SOCERJ</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>247</fpage>
          <lpage>55</lpage>
          <issue>4</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Magalh&#227;es</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fran&#231;a</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Steinberger    J, Daniels S. Obesity, insulin resistance, diabetes, and cardiovascular risk    in children - An American Heart Association scientific statement from the atherosclerosis,    hypertension, and obesity in the young committee (Council on Cardiovascular    Disease in the Young) and the diabetes committee (Council on Nutrition, Physical    Activity, and Metabolism) Circulation. 2003; 107 (10): 1448-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesity, insulin resistance, diabetes, and cardiovascular risk in children - An American Heart Association scientific statement from the atherosclerosis, hypertension, and obesity in the young committee (Council on Cardiovascular Disease in the Young) and the diabetes committee (Council on Nutrition, Physical Activity, and Metabolism)</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1448</fpage>
          <lpage>53</lpage>
          <issue>10</issue>
          <volume>107</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Steinberger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Sociedade Brasileira    de Cardiologia. V Diretrizes brasileiras de hipertens&#227;o. Arq Bras Cardiol.    2006; 87: 1-48.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>V Diretrizes brasileiras de hipertens&#227;o</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1</fpage>
          <lpage>48</lpage>
          <volume>87</volume>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. World Health    Organization (WHO). Obesity: preventing and managing the total epidemic. Report    of a WHO Consultation Group. Geneva: WHO; 1997. [Acesso em 2006 jun. 10]    Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/bmi/index.jsp">http://www.who.int/bmi/index.jsp</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>Obesity: preventing and managing the total epidemic</source>
          <date>
            <year>1997</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Callaway CW,    Chumlea WC, Bouchard C, Himes JH, Lohman TG, Martin AD, et al. Circumferences.    In: Lohman TG, Roche AF, Martorell R (eds). Anthropometric standardization reference    manual. Champaign: Human Kinetics Books; 1991. p. 44-5.</mixed-citation>
        <element-citation publication-type="book">
          <source>Anthropometric standardization reference manual</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>44</fpage>
          <lpage>5</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Callaway</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Chumlea</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Himes</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lohman</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Lohman</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Roche</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Martorell</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Sociedade Brasileira    de Cardiologia. I Diretriz brasileira de diagnostico e tratamento da sindrome    metabolica. Arq Bras Cardiol. 2005; 84 (supl 1): 1-28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>I Diretriz brasileira de diagnostico e tratamento da sindrome metabolica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1</fpage>
          <lpage>28</lpage>
          <volume>84</volume>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Executive Summary    of the Third Report of the National Cholesterol Education Program (NCEP) Expert    Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult    Treatment Panel III). JAMA. 2001; 285: 2486-97.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult Treatment Panel III)</article-title>
          <source>JAMA</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2486</fpage>
          <lpage>97</lpage>
          <volume>285</volume>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Grundy SM,    Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and    management of the metabolic syndrome: an American Heart Association/National    Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:    2735-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement</article-title>
          <source>Circulation</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2735</fpage>
          <lpage>52</lpage>
          <volume>112</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Grundy</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Cleeman</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Donato</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Eckel</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Sociedade Brasileira    de Diabetes. Atualiza&#231;&#227;o brasileira sobre diabetes. [Acesso    em 2008 nov. 2] Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.diabetes.org.br/politicas/abdonline.php">http://www.diabetes.org.br/politicas/abdonline.php</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Atualiza&#231;&#227;o brasileira sobre diabetes</source>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Sociedade Brasileira    de Cardiologia. IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o    da aterosclerose. Arq Bras Cardiol. 2007; 88 (supl 1): S1-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>S1</fpage>
          <lpage>19</lpage>
          <volume>88</volume>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Brand&#227;o    AA, Magalh&#227;es MEC, Freitas EV, Pozzan R, Brand&#227;o AP. Preven&#231;&#227;o    da doen&#231;a cardiovascular: a aterosclerose se inicia na inf&#226;ncia?    Rev SOCERJ. 2004; 17 (1): 37-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preven&#231;&#227;o da doen&#231;a cardiovascular: a aterosclerose se inicia na inf&#226;ncia?</article-title>
          <source>Rev SOCERJ</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>37</fpage>
          <lpage>44</lpage>
          <issue>1</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Magalh&#227;es</surname>
              <given-names>MEC</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Pellanda LC,    Echenique L, Barcellos LMA, Maccari J, Borges FK, Zen BL. Doen&#231;a card&#237;aca    isqu&#234;mica: a preven&#231;&#227;o inicia durante a inf&#226;ncia J    Pediatr. 2002; 78 (2): 91-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Doen&#231;a card&#237;aca isqu&#234;mica: a preven&#231;&#227;o inicia durante a inf&#226;ncia</article-title>
          <source>J Pediatr</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>91</fpage>
          <lpage>6</lpage>
          <issue>2</issue>
          <volume>78</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pellanda</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Echenique</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Barcellos</surname>
              <given-names>LMA</given-names>
            </name>
            <name>
              <surname>Maccari</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Borges</surname>
              <given-names>FK</given-names>
            </name>
            <name>
              <surname>Zen</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Hawkins MA.    Markers of increased cardiovascular risk: are we measuring the most appropriate    parameters? Obes Res. 2004; 12: 107S-114S.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Markers of increased cardiovascular risk: are we measuring the most appropriate parameters?</article-title>
          <source>Obes Res</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>107S</fpage>
          <lpage>114S</lpage>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hawkins</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Rezende DF,    Scarpelli RAB, Souza GF, Costa JO, Scarpelli AMB, Scarpelli PA, et al. Preval&#234;ncia    da hipertens&#227;o arterial sist&#234;mica em escolares de 7 a 14 anos do    munic&#237;pio de Barbacena, Minas Gerais, em 1999. Arq Bras Cardiol. 2003;    81 (4): 375-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preval&#234;ncia da hipertens&#227;o arterial sist&#234;mica em escolares de 7 a 14 anos do munic&#237;pio de Barbacena, Minas Gerais, em 1999</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>375</fpage>
          <lpage>80</lpage>
          <issue>4</issue>
          <volume>81</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rezende</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>RAB</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>AMB</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Kelder SH,    Osganian SK, Feldman HA, Webber LS, Parcel GS, Leupker RV, et al. Tracking of    physical and physiological risk variables among ethnic subgroups from third    to eighth grade: the Child and Adolescent Trial for Cardiovascular Health cohort    study. Prev Med. 2002; 34 (3): 324-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tracking of physical and physiological risk variables among ethnic subgroups from third to eighth grade: the Child and Adolescent Trial for Cardiovascular Health cohort study</article-title>
          <source>Prev Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>324</fpage>
          <lpage>33</lpage>
          <issue>3</issue>
          <volume>34</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kelder</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Osganian</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Webber</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Parcel</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Leupker</surname>
              <given-names>RV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Chen X, Wang    Y. Tracking of blood pressure from childhood to adulthood: a systematic review    and meta-regression analysis. Circulation. 2008; 117 (24): 3171-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>3171</fpage>
          <lpage>80</lpage>
          <issue>24</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Silva MAM,    Rivera IR, Souza MGB, Carvalho ACC. Medida da press&#227;o arterial em crian&#231;as    e adolescentes: recomenda&#231;&#245;es das diretrizes de hipertens&#227;o    arterial e pr&#225;tica m&#233;dica atual. Arq Bras Cardiol. 2007; 88 (4):    491-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Medida da press&#227;o arterial em crian&#231;as e adolescentes: recomenda&#231;&#245;es das diretrizes de hipertens&#227;o arterial e pr&#225;tica m&#233;dica atual</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>491</fpage>
          <lpage>5</lpage>
          <issue>4</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>MAM</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>MGB</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>ACC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Guimar&#227;es    ICB, Almeida AM, Santos AS, Barbosa DBV, Guimar&#227;es AC. Press&#227;o    arterial: efeito do &#237;ndice de massa corporal e da circunfer&#234;ncia    abdominal em adolescentes. Arq Bras Cardiol. 2008; 90 (6): 426-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Press&#227;o arterial: efeito do &#237;ndice de massa corporal e da circunfer&#234;ncia abdominal em adolescentes</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>426</fpage>
          <lpage>32</lpage>
          <issue>6</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>ICB</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>DBV</given-names>
            </name>
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Rosa MLG, Mesquita    ET, Rocha ERR, Fonseca VM. &#205;ndice de massa corporal e circunfer&#234;ncia    da cintura como marcadores de hipertens&#227;o arterial em adolescentes. Arq    Bras Cardiol. 2007; 88 (5): 573-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>&#205;ndice de massa corporal e circunfer&#234;ncia da cintura como marcadores de hipertens&#227;o arterial em adolescentes</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>573</fpage>
          <lpage>8</lpage>
          <issue>5</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rosa</surname>
              <given-names>MLG</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>ERR</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Rabelo LM,    Viana RM, Schimith MA, Patin RV, Valverde MA, Denadai RC, et al. Fatores de    risco para doen&#231;a ateroscler&#243;tica em estudantes de uma universidade    privada em S&#227;o Paulo - Brasil. Arq Bras Cardiol. 1999; 72 (5): 569-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fatores de risco para doen&#231;a ateroscler&#243;tica em estudantes de uma universidade privada em S&#227;o Paulo - Brasil</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>569</fpage>
          <lpage>74</lpage>
          <issue>5</issue>
          <volume>72</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rabelo</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Viana</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Schimith</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Patin</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Valverde</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Denadai</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Eisenmann JC,    Welk GJ, Wickel EE, Blair SN. Aerobics Center Longitudinal Study. Stability    of variables associated with the metabolic syndrome from adolescence to adulthood:    the Aerobics Center Longitudinal Study. Am J Hum Biol. 2004; 16 (6): 690-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aerobics Center Longitudinal Study: Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study</article-title>
          <source>Am J Hum Biol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>690</fpage>
          <lpage>6</lpage>
          <issue>6</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Eisenmann</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Welk</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Wickel</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Blair</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Ricardo DR,    Ara&#250;jo CGS. Body mass index: a scientific evidence-based inquiry. Arq    Bras Cardiol. 2002; 79 (1): 70-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Body mass index: a scientific evidence-based inquiry</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>70</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>79</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ricardo</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Ara&#250;jo</surname>
              <given-names>CGS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Miettinen TA,    Gylling H, Raitakari OT, Hallikainen M, Viikari J. Adolescent cholesterol metabolism    predicts coronary risk factors at middle age: the Cardiovascular Risk in Young    Finns Study. Transl Res. 2008; 151 (5): 260-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Adolescent cholesterol metabolism predicts coronary risk factors at middle age: the Cardiovascular Risk in Young Finns Study</article-title>
          <source>Transl Res</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>260</fpage>
          <lpage>6</lpage>
          <issue>5</issue>
          <volume>151</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Miettinen</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Gylling</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Raitakari</surname>
              <given-names>OT</given-names>
            </name>
            <name>
              <surname>Hallikainen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Viikari</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Carvalho DF,    Paiva AA, Melo ASO, Ramos AT, Medeiros JS, Medeiros CCM, et al. Perfil lip&#237;dico    e estado nutricional de adolescentes. Rev Bras Epidemiol. 2007; 10 (4): 491-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Perfil lip&#237;dico e estado nutricional de adolescentes</article-title>
          <source>Rev Bras Epidemiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>491</fpage>
          <lpage>8</lpage>
          <issue>4</issue>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Paiva</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>ASO</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>CCM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Presi&#243;n arterial en j&#243;venes como marcador de riesgo cardiovascular en j&#243;venes estudio de Rio de Janeiro</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: El estudio de variables de riesgo cardiovascular en poblaciones j&#243;venes es fundamental para estrategias de prevenci&#243;n primaria. OBJETIVO: Evaluar la presi&#243;n arterial (PA), perfil antropom&#233;trico y metab&#243;lico en j&#243;venes del Estudio de Rio de Janeiro, seguidos por 17 a&#241;os. M&#201;TODOS: Se evaluaron 115 individuos (64 masculinos) en tres momentos (seguimiento 212,23&#177;16,0 meses): A1 (12,97&#177;1,48 a&#241;os), A2 (21,90&#177;1,71 a&#241;os) y A3 (30,65&#177;2,00 a&#241;os) y se dividieron en dos grupos: GN (n=84) con por lo menos dos medidas de PA normales en las tres evaluaciones; GH (n=31) con por lo menos dos medidas de PA anormales en las tres evaluaciones. En las tres ocasiones se obtuvieron: PA e &#237;ndice de masa corporal (IMC). En A2 y A3: glucosa, triglic&#233;ridos, colesterol total y fracciones. En A3 se agreg&#243; la circunferencia abdominal (CA). RESULTADOS: 1) Los promedios de la PA, IMC y CA (p&lt;0,0001) y las prevalencias de hipertensi&#243;n arterial (HAS) y sobrepeso/obesidad (S/O) (p&lt;0,003) fueron mayores en el GH en las tres evaluaciones; 2) Los promedios de LDL-c y glucemia (p&lt;0,05) en A2 y la prevalencia de s&#237;ndrome metab&#243;lico (SM) en A3 fueron mayores en el GH; 3) La asociaci&#243;n HAS+S/O tuvo mayor prevalencia en el GH mientras que la asociaci&#243;n PA+IMC normales tuvo mayor prevalencia en el GN (p&lt;0,0001) en las tres evaluaciones; 4) HAS en A1 (RR=5,20 = 5,20; p&lt;0,0007), g&#233;nero masculino (RR=5,26 = 5,26; p&lt;0,0019) y S/O en A1 (RR=3,40 = 3,40; p&lt;0,0278) determinaron aumento de riesgo para HA en la fase adulta joven (A3). CONCLUSI&#211;N: Despu&#233;s de 17 a&#241;os de seguimiento, la PA de individuos j&#243;venes mostr&#243; relaci&#243;n significativa con las variables de riesgo cardiovascular y la ocurrencia de SM en la fase adulta joven.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Presi&#243;n arterial</kwd>
        <kwd>factores de riesgo</kwd>
        <kwd>ni&#241;o</kwd>
        <kwd>adolescente</kwd>
        <kwd>Brasil</kwd>
        <kwd>Rio de Janeiro</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Presi&#243;n arterial en j&#243;venes como marcador de riesgo cardiovascular en j&#243;venes estudio de Rio de Janeiro</bold>
          </label>
          <p>
            <bold>Erika Maria Gon&#231;alves Campana; Andr&#233;a Ara&#250;jo Brand&#227;o; Roberto Pozzan; Maria de F&#225;tima Fran&#231;a; Flavia Lopes Fonseca; Oswaldo L. Pizzi; Maria Eliane Campos Magalh&#227;es; Elizabete Viana de Freitas; Ayrton Pires Brand&#227;o</bold>
          </p>
        </fn>
      </p>
      <p>Universidad del Estado de Rio de Janeiro, Rio de Janeiro, RJ - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> El estudio de variables de riesgo cardiovascular en poblaciones j&#243;venes es fundamental para estrategias de prevenci&#243;n primaria.</p>
      <p><bold>OBJETIVO:</bold> Evaluar la presi&#243;n arterial (PA), perfil antropom&#233;trico y metab&#243;lico en j&#243;venes del Estudio de Rio de Janeiro, seguidos por 17 a&#241;os.</p>
      <p><bold>M&#201;TODOS:</bold> Se evaluaron 115 individuos (64 masculinos) en tres momentos (seguimiento 212,23&#177;16,0 meses): A1 (12,97&#177;1,48 a&#241;os), A2 (21,90&#177;1,71 a&#241;os) y A3 (30,65&#177;2,00 a&#241;os) y se dividieron en dos grupos: GN (n=84) con por lo menos dos medidas de PA normales en las tres evaluaciones; GH (n=31) con por lo menos dos medidas de PA anormales en las tres evaluaciones. En las tres ocasiones se obtuvieron: PA e &#237;ndice de masa corporal (IMC). En A2 y A3: glucosa, triglic&#233;ridos, colesterol total y fracciones. En A3 se agreg&#243; la circunferencia abdominal (CA).</p>
      <p><bold>RESULTADOS:</bold> 1) Los promedios de la PA, IMC y CA (p&lt;0,0001) y las prevalencias de hipertensi&#243;n arterial (HAS) y sobrepeso/obesidad (S/O) (p&lt;0,003) fueron mayores en el GH en las tres evaluaciones; 2) Los promedios de LDL-c y glucemia (p&lt;0,05) en A2 y la prevalencia de s&#237;ndrome metab&#243;lico (SM) en A3 fueron mayores en el GH; 3) La asociaci&#243;n HAS+S/O tuvo mayor prevalencia en el GH mientras que la asociaci&#243;n PA+IMC normales tuvo mayor prevalencia en el GN (p&lt;0,0001) en las tres evaluaciones; 4) HAS en A1 (RR=5,20 = 5,20; p&lt;0,0007), g&#233;nero masculino (RR=5,26 = 5,26; p&lt;0,0019) y S/O en A1 (RR=3,40 = 3,40; p&lt;0,0278) determinaron aumento de riesgo para HA en la fase adulta joven (A3).</p>
      <p><bold>CONCLUSI&#211;N:</bold> Despu&#233;s de 17 a&#241;os de seguimiento, la PA de individuos j&#243;venes mostr&#243; relaci&#243;n significativa con las variables de riesgo cardiovascular y la ocurrencia de SM en la fase adulta joven.</p>
      <p><bold>Palabras Clave:</bold> Presi&#243;n arterial, factores de riesgo, ni&#241;o, adolescente, Brasil, Rio de Janeiro.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La enfermedad cardiovascular (ECV) es la principal causa de muerte en el mundo y en Brasil, y responde por cerca de 300 mil muertes/a&#241;o<sup>1-4</sup>. Estos n&#250;meros justifican la b&#250;squeda por un conocimiento m&#225;s profundo de esta enfermedad, y de sus factores de riesgo (FR), para que podamos ampliar la prevenci&#243;n primaria en nuestro pa&#237;s<sup>5-7</sup>.</p>
      <p>Se sabe que los FR est&#225;n involucrados en ECV en adultos, pero las informaciones sobre sus implicaciones en j&#243;venes todav&#237;a son limitadas<sup>5-7</sup>. No obstante, se sabe que la aterosclerosis se inicia en edad temprana y progresa lentamente hasta la aparici&#243;n de sus complicaciones<sup>8,9</sup>. El Estudio de Bogalusa demostr&#243; que lesiones ateroscler&#243;ticas estaban presentes en aorta y coronaria en individuos j&#243;venes, y que estas lesiones estaban relacionadas con la presencia de FR<sup>5-7</sup>.</p>
      <p>Entender el comportamiento de los FR a lo largo de los a&#241;os es de fundamental importancia, pues &#233;stos tienden a repetirse y agravarse &#151; <italic>"Fen&#243;meno de Rastreo o Tracking"<sup>5</sup></italic> <sup>7,10-16</sup> &#151; y determinan alteraciones progresivas en el aparato cardiovascular<sup>5-7,8,9,10-16</sup>.</p>
      <p>En Brasil, los resultados del Estudio de Rio de Janeiro (ERJ) demostraron que la medida elevada de la presi&#243;n arterial (PA) en la infancia y adolescencia se asoci&#243; a mayores valores de PA, de los &#237;ndices antropom&#233;tricos y mayor Prevalencia de s&#237;ndrome metab&#243;lico (SM) en la fase adulta joven<sup>12-16</sup>.</p>
      <p>Todos estos hallazgos demuestran de forma indudable la asociaci&#243;n entre los FR y la enfermedad ateroscler&#243;tica en las fases iniciales de la vida<sup>17</sup>. No obstante, el camino que lleva a la transici&#243;n del riesgo cardiovascular aumentado en la infancia y a la ECV en el adulto no est&#225; completamente establecido<sup>18</sup>.</p>
      <p>El presente estudio tiene por objetivo evaluar la PA, el perfil antropom&#233;trico y las variables metab&#243;licas en individuos j&#243;venes, estratificados por el comportamiento de su PA obtenida en tres ocasiones, a lo largo de 17 a&#241;os de seguimiento, desde la infancia y la adolescencia.</p>
      <p>
        <bold>Metodolog&#237;a</bold>
      </p>
      <p>La poblaci&#243;n de este estudio se origina del Estudio de Rio de Janeiro<sup>12-16</sup>, una l&#237;nea de investigaci&#243;n sobre PA y otros FR cardiovascular en j&#243;venes y sus familias, que se viene desarrollando en la Universidad del Estado de Rio de Janeiro, desde 1983. Este estudio se realiz&#243; en dos etapas: en la primera, se evaluaron cerca de 3 mil ni&#241;os entre 6 y 9 a&#241;os de edad (1983-1986) en dos fases: escolar y domiciliaria, para determinaci&#243;n de las curvas de normalidad de PA por sexo e intervalo de edades. A partir de 1987, se inici&#243; la segunda etapa del ERJ, evalu&#225;ndose ni&#241;os y adolescentes entre los 10 y 15 a&#241;os de edad y que vienen sigui&#233;ndose a lo largo de cinco fases de evaluaci&#243;n: escolar (1987-1988), domiciliaria (1989-1991), hospitalaria (1992-1995), familiar (1996-1999) y ambulatoria (2004-2008). En esta &#250;ltima es que se introduce el presente estudio (<xref ref-type="fig" rid="f1-body2">Figura 1</xref>). En A1 se examinaron 3.900 ni&#241;os y adolescentes para la determinaci&#243;n de las curvas de normalidad de la PA por sexto e intervalo de edades. En A2 se estudiaron dos grupos de individuos, estratificados por la PA obtenida en A1: El grupo con PA aumentada, definida por una PA<underline>&gt;</underline>p95, y el grupo con PA normal, definida por una PA<underline>&lt;</underline>p50. Estos dos grupos constituyeron una muestra de 385 alumnos objetivo que se estudiaron y se siguieron en las fases subsiguientes del ERJ. De esta manera, los 115 alumnos objetivo que participaron en A3 son representativos de los 385 participantes en A2, no obstante no son representativos de los 3.900 j&#243;venes evaluados en la fase escolar de la segunda etapa del ERJ, como resultado del dise&#241;o del estudio descrito anteriormente.</p>
      <fig id="f1-body2">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf01-es.jpg"/></fig>
      <p>Se evaluaron 115 individuos (64M), designados como alumnos objetivo, de ambos sexos, en seguimiento de 212,23&#177;16,0 meses. Para este estudio se consideraron tres evaluaciones de la segunda etapa del ERJ, a saber: A1 (Fase Escolar): a los 12,97&#177;1,48 a&#241;os (10-16 a&#241;os), A2 (Fase Familiar): a los 21,90&#177;1,71 a&#241;os (18-26 a&#241;os) y A3 (Fase Ambulatoria): a los 30,65&#177;2,00 a&#241;os (27-36 a&#241;os).</p>
      <p>Dos grupos se constituyeron de acuerdo con el comportamiento de la PA, a saber: grupo N (por lo menos dos medidas de PA normales en las tres evaluaciones) con 84 (42 masculinos) individuos y grupo H (por lo menos dos medidas de PA anormales en las tres evaluaciones) con 31(22 masculinos) individuos (<xref ref-type="fig" rid="es_16f2-body2">Figura 2</xref>).</p>
      <p content-type="asset">
        <fig id="es_16f2-body2">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf02-es.jpg"/></fig>
      </p>
      <p>Este estudio fue aprobado por el Comit&#233; de &#201;tica en Investigaci&#243;n del HUPE. Todos los individuos firmaron el t&#233;rmino de consentimiento libre e informado.</p>
      <p>En las tres evaluaciones, se aplic&#243; un cuestionario para el an&#225;lisis de las variables cl&#237;nicas, epidemiol&#243;gicas y socioculturales, se obtuvieron PA, peso (P) y altura (A) y se calcul&#243; el IMC. En A2 y A3 se analizaron, despu&#233;s de 12h de ayuno, glucosa, colesterol, HDL-c, triglic&#233;ridos y se calcul&#243; el LDL-c. En el A2 tambi&#233;n se analiz&#243; la insulina y se calcul&#243; el HOMA-IR. En A3 se agreg&#243; la medida de la circunferencia abdominal (CA).</p>
      <p>La PA se midi&#243; en el miembro superior derecho, con el individuo acostado, utilizando un esfigmoman&#243;metro de columna de mercurio, con manguitos apropiados para el brazo de los individuos<sup>19</sup>. Se realizaron tres registros de la PA, con intervalos de 5 minutos entre cada medida, utiliz&#225;ndose el &#250;ltimo de ellos para el an&#225;lisis. Se consider&#243; HAS en A1 cuando la PA fue <underline>&gt;</underline>percentil 95 para sexo y edad y en A2 y A3, cuando la PA <underline>&gt;</underline>140/90mmHg.</p>
      <p>El IMC se obtuvo por medio del cociente: IMC=P/A<sup>2</sup>. Se consider&#243; peso normal cuando los valores del IMC eran &lt;25kg/m<sup>2</sup>; sobrepeso cuando los valores del IMC se situaban entre 25kg/m<sup>2</sup> y 29,99kg/m<sup>2</sup>; y obesidad cuando los valores del IMC eran <underline>&gt;</underline>30kg/m<sup>20</sup>.</p>
      <p>La circunferencia abdominal se midi&#243; con cinta m&#233;trica inextensible, con precisi&#243;n de 0,1cm, en el punto medio entre la cresta il&#237;aca y el borde inferior de la &#250;ltima costilla<sup>21</sup>. Se definieron como valores aumentados, la CA &gt;102cm para hombres y &gt;88cm para mujeres<sup>22,23</sup>.</p>
      <p>La presencia de s&#237;ndrome metab&#243;lico se defini&#243; de acuerdo con la I Directriz Brasile&#241;a de SM, adopt&#225;ndose el punto de corte para glucemia en ayunas &gt;=100mg/dl, propuesto por Grundy et al.<sup>22,24</sup>.</p>
      <p>Para las variables metab&#243;licas, se consider&#243; valor normal, cuando la glucemia era &lt;100mg/dl; intervalo de intolerancia a la glucosa cuando la glucemia se situaba entre 100mg/ dl y 126mg/dl y DM cuando la glucemia era <underline>&gt;</underline>126mg/d<sup>25</sup>. Los valores de normalidad para el perfil lip&#237;dico siguieron las recomendaciones de la IV Directriz Brasile&#241;a sobre Dislipidemias y Prevenci&#243;n de la Aterosclerosis<sup>26</sup>.</p>
      <p>Las informaciones recogidas se almacenaron en un &#250;nico banco de datos mediante el programa Microsoft Access. Los datos se analizaron mediante el programa estad&#237;stico <italic>SPSS for Windows,</italic> versi&#243;n 8.0.0, Copyright SPSS Inc. 1989 - 1997.</p>
      <p>Se utilizaron los siguientes tests estad&#237;sticos:</p>
      <p>&#149; Test t de Student (t): utilizado para comparaci&#243;n de dos series de datos cuando se cumplen las siguientes condiciones: el promedio y la desviaci&#243;n est&#225;ndar son buenas estimativas de la tendencia central y de la dispersi&#243;n de esos conjuntos, las muestras tienen distribuci&#243;n normal, las poblaciones de donde se retiraron los datos presentan varianzas similares y el n&#250;mero de observaciones es igual para los dos grupos.</p>
      <p>&#149; Teste Chi-cuadrado (&#967;<sup>2</sup>): utilizado para la comparaci&#243;n de las distribuciones de frecuencia de las variables categ&#243;ricas de muestras independientes.</p>
      <p>&#149; El modelo de regresi&#243;n no lineal log&#237;stico se utiliza cuando la variable respuesta es cualitativa con dos resultados posibles (dicot&#243;mica).</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Las caracter&#237;sticas generales de los 115 alumnos objetivo estudiados y de los dos grupos constituidos en base al comportamiento de la PA a lo largo de 17 a&#241;os de seguimiento (GN = Normal y GH = Hipertenso) se presentan en la <xref ref-type="table" rid="es_16t1-body2">Tabla 1</xref>.</p>
      <p content-type="asset">
        <table-wrap id="es_16t1-body2">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt01-es.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Presi&#243;n arterial sist&#243;lica y diast&#243;lica</bold>
      </p>
      <p>En la <xref ref-type="table" rid="es_16t2-body2">Tabla 2</xref> se presentan los promedios de la presi&#243;n arterial sist&#243;lica (PAS) y diast&#243;lica (PAD) en la poblaci&#243;n total y en los grupos en los tres momentos de evaluaci&#243;n A1, A2 y A3. Comparando el comportamiento de la PA entre los</p>
      <p content-type="asset">
        <table-wrap id="es_16t2-body2">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt02-es.jpg"/></table-wrap>
      </p>
      <p>grupos N (GN) y H (GH), se observa que los promedios de las PAS y de la PAD eran mayores en el GH que en el GN con diferencias estad&#237;sticamente significativas en las tres evaluaciones.</p>
      <p>Analizando la variaci&#243;n positiva de la PA al final de 9 a&#241;os (A1 &#8594; A2), no se observaron diferencias estad&#237;sticamente significativas para la variaci&#243;n, tanto de la PAS como de la PAD entre los GN y GH. Al final de 17 a&#241;os (A1 &#8594; A3), se observ&#243; una mayor variaci&#243;n positiva de la PAD en el GN (p=0,024); no se observ&#243; lo mismo para la PAS.</p>
      <p>Las prevalencias de HAS, fueron de 39,10%, 23,50% y 30,40%, en A1, A2 y A3 respectivamente. En las tres evaluaciones el GH present&#243; mayor prevalencia de HA que el GN (p &lt; 0,0001).</p>
      <p>
        <bold>Variables antropom&#233;tricas</bold>
      </p>
      <p>Las variables antropom&#233;tricas pueden ser observadas en la <xref ref-type="table" rid="es_16t3-body2">Tabla 3</xref>.</p>
      <p content-type="asset">
        <table-wrap id="es_16t3-body2">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt03-es.jpg"/></table-wrap>
      </p>
      <p>Fueron observadas mayores promedios de peso e IMC en el GH, con diferencias significativas en las tres evaluaciones. El mismo comportamiento se observ&#243; para la CA obtenida en A3.</p>
      <p>La prevalencia de sobrepeso/obesidad (S/O) en la poblaci&#243;n fue del 25,20%, 30,40% y 53,9% en A1, A2 y A3, respectivamente. El GH present&#243; mayor prevalencia de S/O que el GN en las tres evaluaciones (p &lt; 0,003).</p>
      <p>La prevalencia de CA aumentada en A3 fue del 38,30% en la poblaci&#243;n total, con el 71,00% en el grupo H y el 26,20% en el grupo N (p &lt; 0,0001).</p>
      <p>
        <bold>Variables metab&#243;licas y s&#237;ndrome metab&#243;lico</bold>
      </p>
      <p>Las variables metab&#243;licas obtenidas en A2 y A3 est&#225;n en la <xref ref-type="table" rid="es_16t4-body2">Tabla 4</xref>.</p>
      <p content-type="asset">
        <table-wrap id="es_16t4-body2">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt04-es.jpg"/></table-wrap>
      </p>
      <p>Cuando se compar&#243; el comportamiento de los grupos en A2 y A3, se observ&#243; que el GH present&#243; un perfil metab&#243;licamente m&#225;s desfavorable (mayores promedios de Col T, LDL-c, TGL, G e insulinemia, y menores promedios de HDL-c) cuando se lo compara con el GN, aunque se hayan observado diferencias estad&#237;sticamente significativas s&#243;lo para el LDL-c y la glucemia en A2.</p>
      <p>Las alteraciones metab&#243;licas que componen un perfil de riesgo desfavorable (HDL-c bajo, insulinemia aumentada, intolerancia a la glucosa &#151; definida como HOMA-IR IR &gt;percentil 95 para sexo y edad en A2, o como glucemia en ayunas &gt;100 y &lt; 126mg/dl en A3) as&#237; como el s&#237;ndrome metab&#243;lico, fueron m&#225;s prevalentes en el GH (<xref ref-type="table" rid="es_16t5-body2">Tabla 5</xref>).</p>
      <p content-type="asset">
        <table-wrap id="es_16t5-body2">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt05-es.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Comportamiento de la PA y del IMC asociados</bold>
      </p>
      <p>Considerando la presencia o ausencia de PA aumentada y la presencia o ausencia de S/O, en las tres evaluaciones (A1, A2 y A3), se observ&#243; la combinaci&#243;n de estas dos condiciones en cuatro modelos: [PA normal + IMC normal]; [PA normal + IMC elevado]; [PA elevada + IMC normal] y [PA elevada + IMC elevado]. Se observ&#243; que el modelo de asociaci&#243;n m&#225;s desfavorable [PA elevada + IMC elevado] present&#243; mayor prevalencia en el GH en los tres momentos de evaluaci&#243;n. De forma inversa, para el modelo de asociaci&#243;n normal [PA normal + IMC normal] se observ&#243; mayor prevalencia en el GN en los tres momentos de la evaluaci&#243;n. Las prevalencia de los cuatro modelos de asociaci&#243;n en A1, A2 y A3 est&#225;n representadas en la Figura 4.</p>
      <p>
        <bold>An&#225;lisis de regresi&#243;n log&#237;stica</bold>
      </p>
      <p>Para el an&#225;lisis del riesgo relativo se construy&#243; un modelo de regresi&#243;n log&#237;stica en que la variable dependiente utilizada fue la HAS en A3 y las variables independientes analizadas fueron la presencia o ausencia de HAS en A1, el g&#233;nero y la presencia o ausencia de S/O en A1.</p>
      <p>Se observ&#243; que la presencia de HAS en A1 (RR: 5,20; p &lt; 0,0007), el g&#233;nero masculino (RR: 5,26; p &lt; 0,0019) y la presencia de S/O en A1 (RR: 3,40; p &lt; 0,0278) determinaron un aumento de riesgo para ocurrencia de HAS en A3.</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Estudiar el comportamiento de los FR cardiovascular desde la infancia y adolescencia hasta la fase adulta es de fundamental importancia para la adopci&#243;n de medidas de prevenci&#243;n primaria<sup>5-7,17,27-29</sup>.</p>
      <p>Se ha estado analizando el comportamiento de la PA en varias poblaciones de j&#243;venes y existen cada vez m&#225;s indicios de que la PA en la infancia se correlaciona con la PA en la edad adulta y de que la HAS en ni&#241;os es un importante FR para el desarrollo futuro de EAC<sup>27-32</sup>. En el presente estudio, la repetici&#243;n de valores normales y anormales de PA a partir de la infancia y de la adolescencia permiti&#243; separar dos grupos de individuos j&#243;venes que presentan las variables que componen los FR cardiovascular con comportamientos diferentes, reforzando la importancia de observar estas variables desde intervalos de edades m&#225;s precoces.</p>
      <p>Se sabe que la PA tiende a aumentar a partir del nacimiento, a lo largo de la infancia y adolescencia<sup>30,31</sup>. En este an&#225;lisis de la cohorte del ERJ, se observ&#243; un comportamiento similar, presentando un incremento progresivo de la PA con la edad, verificado por la variaci&#243;n positiva de la PAS y de la PAD a lo largo de los 17 a&#241;os de seguimiento tanto en el GN como en el GH.</p>
      <p>Los valores de PA observados en la infancia tienden a mantenerse en el mismo intervalo de percentil a lo largo del tiempo, lo que significa que los ni&#241;os con percentiles m&#225;s elevados de PA tienden a mantenerse en los percentiles m&#225;s</p>
      <p>elevados hasta la edad adulta<sup>17,27,30-32</sup>. En los tres momentos de evaluaci&#243;n, los promedios de PA y las prevalencias de HAS siempre fueron mayores en el GH que en el GN, sugiriendo que ni&#241;os y adolescentes presentan un patr&#243;n de comportamiento de la PA a lo largo del tiempo. Cabe destacar que el dise&#241;o original del Estudio de Rio de Janeiro se caracteriz&#243; por el seguimiento de individuos j&#243;venes con comportamientos distintos de la PA en la fase escolar: con percentil de PA&gt;=95 y con percentil de PA&lt;=50. De esta forma, en fases subsiguientes del estudio, se esperan tasas de prevalencia de HAS m&#225;s elevadas que las observadas en la poblaci&#243;n general de ese intervalo de edades joven.</p>
      <p>La composici&#243;n corporal es uno de los principales factores determinantes de la PA en ni&#241;os. Existe una relaci&#243;n directa entre el peso y la PA, en especial en la segunda d&#233;cada de vida<sup>33-35</sup>. En nuestro pa&#237;s, diversas publicaciones de la cohorte del ERJ ya indicaban la importancia de la composici&#243;n corporal en la determinaci&#243;n de la PA en ni&#241;os y adolescentes<sup>12-16</sup>. En el presente estudio, se observaron promedios de peso, altura y del IMC mayores en el GH en los tres momentos de evaluaci&#243;n, demostrando haber tambi&#233;n en esta poblaci&#243;n una asociaci&#243;n entre composici&#243;n corporal y PA. De manera similar a lo relatado en la bibliograf&#237;a<sup>12-16,33-35</sup> se observ&#243; un aumento progresivo de las prevalencias de IMC aumentando a lo largo de los 17 a&#241;os de seguimiento (A1 = 25,2% - A2 = 30,4% - A3 = 53,9%). Reforzando el conocimiento de la asociaci&#243;n entre S/O y HAS en este intervalo de edades, se observ&#243; que desde la infancia hasta el momento actual, los alumnos objetivo pertenecientes al GH presentaron mayores prevalencias de S/O.</p>
      <p>Un aspecto relevante es conocer el patr&#243;n de distribuci&#243;n corporal de la grasa y su relaci&#243;n con los FR en poblaciones j&#243;venes<sup>34,35</sup>. En la muestra de estudio, la asociaci&#243;n entre obesidad central y PA result&#243; evidente, con mayor promedio de CA en A3 en los individuos del GH.</p>
      <p>
        <xref ref-type="fig" rid="es_16f3-body2">Figura 3</xref>
      </p>
      <p content-type="asset">
        <fig id="es_16f3-body2">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf03-es.jpg"/></fig>
      </p>
      <p>Adem&#225;s de ello, es importante estudiar la agregaci&#243;n de HAS y S/O, por su potencial desforavorable<sup>11,36-38</sup>. Los resultados del presente estudio est&#225;n en desacuerdo con la bibliograf&#237;a<sup>36-38</sup>, demostrando un aumento progresivo en la prevalencia de la asociaci&#243;n [HAS + S/O] a lo largo de los 17 a&#241;os de seguimiento (A1 = 15,7% &#8594; A3 = 27%). Si se considera la condici&#243;n de por lo menos uno de los factores presentes (HAS o S/O) se observa que este perfil desfavorable de riesgo tambi&#233;n ser volvi&#243; m&#225;s prevalente a lo largo del seguimiento estando presente en casi el 60% (57,5%) de los alumnos objetivo en la fase actual (A3).</p>
      <p>En el presente estudio, los individuos pertenecientes al GH presentaron un perfil metab&#243;lico m&#225;s desfavorable que los individuos del GN, con mayores promedios de Col T, LDL-c, TGL y menores promedios de HDL-c. En los individuos pertenecientes al GH, la prevalencia de valores bajos de HDL-c fue casi el doble de los individuos del GN, lo que refuerza el perfil de riesgo CV desfavorable en ese grupo de j&#243;venes.</p>
      <p>La agregaci&#243;n de FR en adultos es bastante com&#250;n en la pr&#225;ctica cl&#237;nica. En los &#250;ltimos a&#241;os esta misma asociaci&#243;n viene siendo documentada en la poblaci&#243;n joven<sup>12-16,22,24,37</sup>. El s&#237;ndrome metab&#243;lico (SM), importante representante de la agregaci&#243;n de FR, es una condici&#243;n asociada a altas morbilidad y mortalidad cardiovasculares y al elevado costo socioecon&#243;mico<sup>12,14-16,22,37</sup>.</p>
      <p>En la poblaci&#243;n estudiada, se observ&#243; un perfil metab&#243;licamente m&#225;s d esfavorable en los alumnos objetivo que pertenec&#237;an al GH. As&#237; como se observa en la bibliograf&#237;a<sup>39,40</sup>, el HDL-c bajo fue una alteraci&#243;n altamente prevalente (61,3%) en esta poblaci&#243;n. Otros elementos que forma parte del contexto del SM y reflejan la alteraci&#243;n de la tolerancia a la glucosa y resistencia insul&#237;nica (HOMA-IR), glucemia en ayunas anormal y niveles de insulina s&#233;rica elevados tambi&#233;n fueron m&#225;s prevalentes en los individuos pertenecientes al GH, de forma concordante con la bibliograf&#237;a<sup>12,16,39,40</sup>. La prevalencia de SM present&#243; distribuci&#243;n similar, siendo m&#225;s prevalente entre los alumnos objetivo del GH.</p>
      <p>Cabe considerar adem&#225;s el impacto de algunos FR modificables y no modificables en el aumento del riesgo de desarrollo de las ECV. En el conjunto de FR no modificables, la edad y el g&#233;nero son de reconocida importancia en la determinaci&#243;n de la ECV. El g&#233;nero masculino est&#225; asociado a un mayor riesgo cardiovascular<sup>8,11,17,26,27</sup>. En el an&#225;lisis de regresi&#243;n log&#237;stica los principales factores relacionados con la ocurrencia de HAS en la edad adulta joven fueron: el g&#233;nero masculino (5,26; IC 95% 1,8438 - 15,0353; p = 0,0019), la presencia de HAS (5,20; IC 95% 1,9986 - 13,5061; p = 0,007) y la presencia de S/O (3,40 IC95% 1,1430 - 10,1046; p = 0,0278) en la infancia y adolescencia (A1), resaltando que, adem&#225;s de g&#233;nero masculino, la presencia de HAS y S/O en A1 son importantes para el perfil de riesgo cardiovascular en la fase adulta joven.</p>
      <p>La principal limitaci&#243;n de este estudio es la misma experimentada por diversas cohortes existentes en la bibliograf&#237;a y se relaciona con el car&#225;cter longitudinal del seguimiento que determina p&#233;rdidas progresivas de una parte de la muestra original. No obstante, se destaca que la muestra poblacional del Estudio de Rio de Janeiro es una muestra no hospitalaria y que se viene siguiendo en los &#250;ltimos 17 a&#241;os, constituyendo una cohorte brasile&#241;a de este intervalo de edades con el m&#225;s largo seguimiento hasta los d&#237;as actuales.</p>
      <p>En conclusi&#243;n, el mantenimiento de niveles elevados de presi&#243;n arterial desde la infancia hasta la edad adulta joven se correlacion&#243; con un perfil de riesgo cardiovascular m&#225;s desfavorable representado por mayores prevalencias de hipertensi&#243;n arterial, sobrepeso/obesidad, alteraciones lip&#237;dicas y glic&#237;dicas y la presencia de s&#237;ndrome metab&#243;lico en la fase adulta joven. Los hallazgos sugieren que medidas de prevenci&#243;n primaria de los factores de riesgo cardiovascular deben iniciarse en la infancia y adolescencia.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio fue financiado parcialmente por la Fundaci&#243;n de Amparo a la Investigaci&#243;n del Estado de Rio de Janeiro &#151; Faperj.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de la tesis de Maestr&#237;a de Erika Maria Gon&#231;alves Campana, de la Universidad del Estado de Rio de Janeiro.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Blood pressure in young individuals as a cardiovascular risk marker. The Rio de Janeiro study</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The study of the cardiovascular risk variables in young populations is fundamental to establish primary prevention strategies. OBJECTIVE: To evaluate the blood pressure (BP), anthropometric and metabolic profile in young individuals from The Rio de Janeiro Study, followed by 17 years. METHODS: A total of 115 individuals (64 males) were evaluated at three different moments (follow-up: 212.23&#177;16.0 months): A1 (12.97&#177;1.48 years), A2 (21.90&#177;1.71 years) and A3 (30.65&#177;2.00 years) and divided in two groups: NG (n=84) with at least two normal BP measurements at the three assessments; HG (n=31) with at least two abnormal BP measurements at the three assessments. BP and body mass index (BMI) were obtained at the three assessments. Levels of glucose, triglycerides, total cholesterol and fractions were obtained at A2 and A3. Abdominal circumference (AC) was obtained only at A3. RESULTS: 1) The means of BP, BMI and AC (p&lt;0.0001) as well as the prevalence of systemic arterial hypertension (SAH) and overweight/obesity (O/O) (p&lt;0.003) were higher in the HG at the three assessments; 2) The means of LDL-c and glycemia (p&lt;0.05) at A2 and the prevalence of metabolic syndrome (MS) at A3 were higher in the HG; 3) the association SAH+O/O was more prevalent in the HG, whereas the association NBP+NBMI was more prevalent in the NG (p&lt;0.0001) at the three assessments; 4) SAH at A1 (RR=5.20 = 5.20; p&lt;0.0007), male gender (RR=5.26 = 5.26; p&lt;0.0019) and OO at A1 (RR=3.40 = 3.40; p&lt;0.0278) determined an increased risk for AH at the young adult life (A3). CONCLUSION: After 17 years of follow-up, the BP of young individuals showed a significant association with the cardiovascular risk variables and the occurrence of MS at the young adult life.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>blood pressure</kwd>
        <kwd>risk factors</kwd>
        <kwd>child</kwd>
        <kwd>adolescent</kwd>
        <kwd>Brazil</kwd>
        <kwd>Rio de Janeiro</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Blood pressure in young individuals as a cardiovascular risk marker. The Rio de Janeiro study</bold>
          </label>
          <p>
            <bold>Erika Maria Gon&#231;alves Campana; Andr&#233;a Ara&#250;jo Brand&#227;o; Roberto Pozzan; Maria de F&#225;tima Fran&#231;a; Flavia Lopes Fonseca; Oswaldo L Pizzi; Maria Eliane Campos Magalh&#227;es; Elizabete Viana de Freitas; Ayrton Pires Brand&#227;o</bold>
          </p>
        </fn>
      </p>
      <p>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> The study of the cardiovascular risk variables in young populations is fundamental to establish primary prevention strategies.</p>
      <p><bold>OBJECTIVE:</bold> To evaluate the blood pressure (BP), anthropometric and metabolic profile in young individuals from The Rio de Janeiro Study, followed by 17 years.</p>
      <p><bold>METHODS:</bold> A total of 115 individuals (64 males) were evaluated at three different moments (follow-up: 212.23&#177;16.0 months): A1 (12.97&#177;1.48 years), A2 (21.90&#177;1.71 years) and A3 (30.65&#177;2.00 years) and divided in two groups: NG (n=84) with at least two normal BP measurements at the three assessments; HG (n=31) with at least two abnormal BP measurements at the three assessments. BP and body mass index (BMI) were obtained at the three assessments. Levels of glucose, triglycerides, total cholesterol and fractions were obtained at A2 and A3. Abdominal circumference (AC) was obtained only at A3.</p>
      <p><bold>RESULTS:</bold> 1) The means of BP, BMI and AC (p&lt;0.0001) as well as the prevalence of systemic arterial hypertension (SAH) and overweight/obesity (O/O) (p&lt;0.003) were higher in the HG at the three assessments; 2) The means of LDL-c and glycemia (p&lt;0.05) at A2 and the prevalence of metabolic syndrome (MS) at A3 were higher in the HG; 3) the association SAH+O/O was more prevalent in the HG, whereas the association NBP+NBMI was more prevalent in the NG (p&lt;0.0001) at the three assessments; 4) SAH at A1 (RR=5.20 = 5.20; p&lt;0.0007), male gender (RR=5.26 = 5.26; p&lt;0.0019) and OO at A1 (RR=3.40 = 3.40; p&lt;0.0278) determined an increased risk for AH at the young adult life (A3).</p>
      <p><bold>CONCLUSION: </bold> After 17 years of follow-up, the BP of young individuals showed a significant association with the cardiovascular risk variables and the occurrence of MS at the young adult life.</p>
      <p><bold>Key words:</bold> Blood pressure; risk factors; child; adolescent; Brazil; Rio de Janeiro.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The cardiovascular disease (CVD) is the main cause of death in the world and it is accountable for around 300,000 deaths/year in Brazil<sup>1-4</sup>. These figures justify the search for a more profound knowledge of the disease and its risk factors (RF), so that the primary prevention can be increased in our country<sup>5-7</sup>.</p>
      <p>It is acknowledged that the RF are involved in the CVD in adult individuals; however, the information on their implications in young individuals is still limited<sup>5-7</sup>. However, it is known that atherosclerosis starts at an early age and slowly progresses until the onset of its complications<sup>8,9</sup>. The Bogalusa Study showed that atherosclerotic lesions were present in the aorta and coronaries of young individuals and that these lesions were related to the presence of RF<sup>5-7</sup>.</p>
      <p>It is of fundamental importance to understand the behavior of risk factors throughout the years, as they tend to repeat and worsen - "The Trail or Tracking Phenomenon<italic>"</italic><sup>5-7,10-16</sup> - and determine progressive alterations in the cardiovascular system<sup>5-7,8,9, 10-16</sup>.</p>
      <p>In Brazil, the results of the Rio de Janeiro Study (ERJ) have demonstrated that high blood pressure (BP) levels in childhood and adolescence are associated with higher BP levels, anthropometric values and a higher prevalence of metabolic syndrome (MS) at the young adult phase<sup>12-16</sup>.</p>
      <p>All these findings undeniably demonstrate an association between RF and atherosclerotic disease at the early phases of life<sup>17</sup>. However, the pathway that leads to the transition from increased cardiovascular risk in childhood to CVD in adulthood has yet to be fully established<sup>18</sup>.</p>
      <p>The present study aims at evaluating BP, the anthropometric profile and the metabolic variables in young individuals, stratified by the BP behavior obtained at three different moments, throughout 17 years of follow-up, since childhood and adolescence.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>The study population is originated from the Rio de Janeiro Study<sup>12-16</sup>, a line of research on blood pressure (BP) and other cardiovascular RF in young individuals and their families, which has been developed at the Universidade do Estado do Rio de Janeiro since 1983. The present study was carried out in two phases: in the first, around 3,000 children between 6 and 9 years were evaluated (1983-1986) at two phases: school and home, to determine the curves of normality for BP by sex and age range. From 1987 on, the second phase of the ERJ was started and children and adolescents aged 10 to 15 years, who have been followed throughout five phases of assessment: school (1987-1988), home (1989-1991), hospital (1992-1995), family (1996-1999) and ambulatory (2004-2008) were evaluated. The present study is part of this last phase (<xref ref-type="fig" rid="f1-body3">Figure 1</xref>). A total of 3,900 children were assessed in A1 to determine the normality curves of BP by sex and age range. In A2, two groups of individuals were studied, stratified by the BP obtained in A1: the group with increased BP, defined by a BP level <underline>&gt;</underline>95p, and the group with normal BP, defined as BP level <underline>&lt;</underline>50p. These two groups comprehended a sample of 385 target-students that were studied and followed at the subsequent phases of the ERJ. Therefore, the 115 students that participated in A3 are representative of the 385 participants in A2; however, they are not representative of the 3,900 young individuals evaluated at the school phase of the second phase of the ERJ, due to the design of the previously described study.</p>
      <fig id="f1-body3">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf01-en.jpg"/></fig>
      <p>We evaluated 115 individuals (64 males), designated as target-students, of both sexes, during a follow-up of 212.23&#177;16.0 months. For the present study, three evaluations of the second phase of the ERJ were considered, as follows: A1 (School phase): at 12.97&#177;1.48 years (10-16 yrs), A2 (Family phase): at 21.90&#177;1.71 years (18-26 yrs) and A3 (Ambulatory phase): at 30.65&#177;2.00 years (27-36 yrs).</p>
      <p>Two groups were formed according to the behavior of the BP, as follows: group N (at least two normal BP measurements at the three assessments), with 84 individuals (42 males) and group H (at least two abnormal BP measurements at the three assessments) with 31 individuals (22 males) (<xref ref-type="fig" rid="f2-body3">Figure 2</xref>).</p>
      <fig id="f2-body3">
        <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf02-en.jpg"/></fig>
      <p>The study was approved by the Ethics Committee in Research of HUPE. All individuals signed the Free and Informed Consent Form.</p>
      <p>A questionnaire was applied at the three assessments to analyze the clinical, epidemiological and sociocultural variables and BP, weight (W) and height (H) were obtained and the body mass index (BMI) was calculated. At A2 and A3, blood glucose, total cholesterol, HDL-c and triglycerides were measured after a 12-hour fasting and LDL-c was calculated. Also at A2, insulin levels were measured and the HOMA-IR was calculated. At A3, the measurement of the abdominal circumference (AC) was added.</p>
      <p>The BP was measured in the right upper limb, with the individual lying down, using a mercury column sphygmomanometer, with appropriate cuffs for the individuals' arms<sup>19</sup>. Three BP measurements were carried out, with a 5-minute interval between each measurement and the last one was used for the analysis. Systemic arterial hypertension (SAH) was considered when the BP at A1 was <underline>&gt;</underline> 95 percentile for sex and age and at A2 and A3, when BP <underline>&gt;</underline>140/90 mmHg.</p>
      <p>The BMI was obtained through the ratio: BMI=W/H<sup>2</sup>. A normal weight was considered when the BMI values were &lt;25kg/m&#178;; overweight was considered when BMI was between 25kg/m&#178; and 29.99kg/m<sup>2</sup>; and obesity when BMI values were <underline>&gt;</underline>30kg/m<sup>20</sup>.</p>
      <p>The abdominal circumference was measured using an inextensible measurement tape with a 0.1-cm precision, at the midpoint between the iliac crest and the lower border of the last rib<sup>21</sup>. Increased AC values were defined as AC&gt; 102 cm for males and &gt; 88 cm for females<sup>22,23</sup>.</p>
      <p>The presence of metabolic syndrome (MS) was defined according to the I Brazilian Guidelines on MS, using the cutoff for fasting glycemia <underline>&gt;</underline> 100 mg/dl proposed by Grundy and cols<sup>22,24</sup>.</p>
      <p>For the metabolic variables, a normal value was considered when glycemia was &lt;100mg/dl; glucose intolerance when the glycemia was between 100mg/dl and 126mg/dl and DM when the glycemia was <underline>&gt;</underline>126mg/d<sup>25</sup>. The normal values for the lipid profile followed the recommendations of the IV Brazilian Guidelines on Dyslipidemia and Atherosclerosis Prevention<sup>26</sup>.</p>
      <p>The data obtained were stored in a single database using the Microsoft Access program. The data were analyzed using the statistical program <italic>SPSS for Windows</italic>, version 8.0.0, Copyright SPSS Inc., 1989 - 1997.</p>
      <p>The following statistical tests were used:</p>
      <p>&#149; Student's <italic>t</italic> test (t): used for the comparison of two sets of data when the following conditions are considered: the mean and standard deviation are good estimates of the central tendency and of the dispersion of these sets; the samples have normal distribution; the populations from where the data were obtained have similar variances and the number of observations is the same for both sets.</p>
      <p>&#149; Chi-square Test (&#967;<sup>2</sup>): used for the comparison of the frequency distributions of the categorical variables of independent samples.</p>
      <p>&#149; The logistic non-linear regression model is used when the response variable is qualitative with two possible results (dichotomous).</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>The general characteristics of the 115 target-students and of the two groups created based on the BP behavior throughout the 17 years of follow-up (NG = Normal and HG=Hypertensive) are shown in <xref ref-type="table" rid="en_16t1-body3">Table 1</xref>.</p>
      <p content-type="asset">
        <table-wrap id="en_16t1-body3">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt01-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Systolic and diastolic arterial pressure</bold>
      </p>
      <p><xref ref-type="table" rid="en_16t2-body3">Table 2</xref> shows the means of the systolic (SAP) and diastolic arterial pressure (DAP) in the total population and in the groups at the three moments of assessment, A1, A2 and A3. When comparing the BP behavior between the groups N (NG) and H (HG), it can be observed that the SAP and DAP means were higher in the HG than in the NG, with statistically significant differences at the three assessments.</p>
      <p content-type="asset">
        <table-wrap id="en_16t2-body3">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt02-en.jpg"/></table-wrap>
      </p>
      <p>When analyzing the positive variation of the BP at the end of 9 years (A1&#8594; A2), no statistically significant differences were observed regarding the variation of the SAP, as well as of the DAP, between the NG and the HG. At the end of 17 years (A1&#8594; A3), a higher positive variation of DAP was observed in the HG (p=0.024); the same was not observed for SAP.</p>
      <p>The prevalence of SAH was 39.10%, 23.50% and 30.40%, at A1, A2 and A3 respectively. The HG presented a higher prevalence of SAH at the three assessments, when compared to the NG (p &lt; 0.0001).</p>
      <p>
        <bold>Anthropometric variables</bold>
      </p>
      <p>The anthropometric variables can be found in <xref ref-type="table" rid="en_16t3-body3">Table 3</xref>. Higher means of weight and BMI were observed in HG, with statistically significant differences at the three assessments. The same was observed regarding the AC obtained at A3.</p>
      <p content-type="asset">
        <table-wrap id="en_16t3-body3">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt03-en.jpg"/></table-wrap>
      </p>
      <p>The prevalence of overweight/obesity (O/O) in the studied population was 25.20%, 30.40% and 53.9% at A1, A2 and A3, respectively. The HG presented a higher prevalence of O/O when compared to the NG at the three assessments (p &lt; 0.003). The prevalence of increased AC at A3 was 38.30% in the total population, with 71.00% in the HG and 26.20% in the NG (p &lt; 0.0001).</p>
      <p>
        <bold>Metabolic variables and metabolic syndrome</bold>
      </p>
      <p>The metabolic variables obtained at A2 and A3 are shown in <xref ref-type="table" rid="en_16t4-body3">Table 4</xref>.</p>
      <p content-type="asset">
        <table-wrap id="en_16t4-body3">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt04-en.jpg"/></table-wrap>
      </p>
      <p>When the behavior of the groups was compared at A2 and A3, it was observed that the HG showed a more unfavorable metabolic profile (higher means of TC, LDL-c, TGL, glycemia and insulinemia and lower means of HDL-c) when compared to the NG, although statistically significant differences were observed only for LDL-c and glycemia at A2.</p>
      <p>The metabolic alterations that comprehend an unfavorable risk profile (low HDL-c, increased insulinemia, glucose intolerance - defined as HOMA-IR &gt; 95<sup>th</sup> percentile for sex and age at A2, or as fasting glycemia &gt; 100 and &lt; 126 mg/dl at A3), as well as the presence of MS were more prevalent in the HG (<xref ref-type="table" rid="en_16t5-body3">Table 5</xref>).</p>
      <p content-type="asset">
        <table-wrap id="en_16t5-body3">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gt05-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Association of BP behavior and BMI</bold>
      </p>
      <p>Considering the presence or absence of increased BP and the presence or absence of O/O at the three assessments (A1, A2 and A3), a combination of these two conditions was observed in four different models: [ normal BP+ normal BMI]; [normal BP+ elevated BMI]; [elevated BP + normal BMI] and [elevated BP + elevated BMI]. It was observed that the most unfavorable association model [ elevated BP+ elevated BMI] presented a higher prevalence at the HG at the three assessments. Inversely, for the normal association model [ normal BP+ normal BMI], a higher prevalence was observed in the NG at the three assessments. The prevalence of the four association models at A1, A2 and A3 are shown in <xref ref-type="fig" rid="en_16f3-body3">Figure 3</xref>.</p>
      <p content-type="asset">
        <fig id="en_16f3-body3">
          <graphic xlink:href="1678-4170-abc-93-06-0657-00016-gf03-en.jpg"/></fig>
      </p>
      <p>
        <bold>Logistic regression analysis</bold>
      </p>
      <p>A model of logistic regression analysis was built for the analysis of the relative risk (RR), where the dependent variable used was the SAH at A3 and the independent variables analyzed were the presence or absence of SAH at A1, the gender and the presence or absence of O/O at A1. It was observed that the presence of SAH at A1 (RR: 5.20; p &lt; 0.0007), the male gender (RR: 5.26; p &lt; 0.0019) and the presence of de O/O at A1 (RR: 3.40; p &lt; 0.0278) determined an increased risk for the occurrence of SAH at A3.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>It is of fundamental importance to study the behavior of the cardiovascular RF since childhood and adolescence until the adult age, in order to adopt primary prevention measures<sup>5-7,17,27-29</sup>.</p>
      <p>The BP behavior has been analyzed in several populations of young individuals and there is increasing evidence that the BP in childhood is correlated with the BP in the adult life and that SAH in children is an important RF for the future development of CAD<sup>27-32</sup>.</p>
      <p>In the present study, the repetition of normal and abnormal BP values from childhood and adolescence allowed us to separate the participants in two groups of young individuals that presented the variables that comprehend the cardiovascular RF with different behaviors, reinforcing the importance of observing these variables from the earlier age ranges.</p>
      <p>It is known that the BP tends to increase from birth, throughout childhood and adolescence<sup>30,31</sup>. In this analysis of the ERJ cohort, a similar behavior was observed, with a progressive BP increase with age, verified through the positive variation of the SAP and DAP during the 17 years of follow-up in both the NG and HG.</p>
      <p>The BP values observed in childhood tend to remain in the same percentile range with time, which means that the children with higher BP percentiles tend to remain in the higher percentiles until the adult age<sup>17,27,30-32</sup>. The BP means and the SAH prevalence were always higher in the HG than in the NG at the three assessments, suggesting that children and adolescents present a pattern of BP behavior throughout time. It is worth mentioning that the original design of the Rio de Janeiro Study (ERJ) was characterized by the follow-up of young individuals with distinct BP behaviors at the school phase: with a BP percentile <underline>&gt;</underline>95 or with a BP percentile <underline>&lt;</underline>50. Therefore, in the subsequent phases of the study, higher SAH prevalence rates are expected than those observed in the general population within this age range.</p>
      <p>The body composition is one of the main BP determinants in children. There is a direct association between weight and BP, especially in the second decade of life<sup>33-35</sup>. In our country, several ERJ cohort publications had already shown the importance of the body composition in BP determinism in children and adolescents<sup>12-16</sup>. In the present study, higher weight, height and BMI means were observed in HG at the three assessments, showing that this population also presented an association between body composition and BP.</p>
      <p>Similarly to what has been reported in the literature<sup>12-16,33-35</sup>, a progressive increase in the prevalence of increased BMI was observed throughout the 17 years of follow-up (A1 = 25.2% &#8594; A2 = 30.4% &#8594; A3 = 53.9%). Reinforcing the knowledge of the association between O/O and SAH in this age range, it was observed that, from childhood to the present moment, the target-students that belonged to the HG presented higher prevalence of O/O.</p>
      <p>A relevant aspect is to know the pattern of body fat distribution and its association with the RF in young populations<sup>34,35</sup>. In the study sample, the association between central obesity and BP was evident, with the individuals from the HG presenting a higher mean AC at A3. Additionally, it is important to study the association of SAH and O/O, due to its unfavorable potential<sup>11,36-38</sup>. The results of the present study are in agreement with those in the literature<sup>36-38</sup> demonstrating a progressive increase in the prevalence of the association [SAH + O/O] throughout the 17 years of follow-up (A1 = 15.7% &#8594; A3 = 27%). If the condition of at least one of the present factors (SAH or O/O) is considered, it can be observed that this unfavorable risk profile also became more prevalent throughout the follow-up, being present in almost 60% (57.5%) of the target-students in the current phase (A3).</p>
      <p>In the present study, the individuals from the HG presented a more unfavorable metabolic profile than those in the NG, with higher TC, LDL-c and TGL means and lower HDL-c means. Among the individuals from the HG, the prevalence of low HDL-c levels was almost two-fold higher than among those from the NG, which reinforces the unfavorable CV risk profile in this group of young individuals.</p>
      <p>The aggregation of RF in adults is very common in clinical practice. In the last years, this same association has been documented in the young population<sup>12-16,22,24,37</sup>. The metabolic syndrome (MS), an important representation of the RF aggregation, is a condition associated with high cardiovascular morbidity and mortality and with the elevated socioeconomic cost<sup>12,14-16,22,37</sup>.</p>
      <p>In the studied population, a more unfavorable metabolic profile was observed among the target-students from the HG. As observed in the literature<sup>39,40</sup>, the low HDL-c was a highly prevalent alteration (61.3%) in this population. Other elements that are part of the context of the MS and reflect the alteration in glucose tolerance and insulin resistance (HOMA-IR, abnormal fasting glycemia and high serum insulin levels) were also more prevalent in individuals from the HG, in agreement with the literature<sup>12,16,39,40</sup>. The prevalence of MS presented a similar distribution, being more prevalent among the target-students from the HG.</p>
      <p>It is also important to consider the impact of some modifiable and non-modifiable RF on the increased risk of CVD development. Among the non-modifiable RF, age and gender are acknowledged to be important in CVD determinism. The male gender is associated with a higher cardiovascular risk<sup>8,11,17,26,27</sup>. At the logistic regression analysis, the main factors related to the occurrence of SAH at the adult age were: male gender (5.26; 95%CI: 1.8438 - 15.0353; p = 0.0019), presence of SAH (5.20; 95%CI: 1.9986 - 13.5061; p = 0.007) and the presence of O/O (3.40; 95%CI 1.1430 - 10.1046; p = 0.0278) in childhood and adolescence (A1), emphasizing that, in addition to the male gender, the presence of SAH and O/O at A1 are important for the cardiovascular risk profile at the young adult phase.</p>
      <p>The main limitation of the present study is the same experiences by several other cohorts in the literature and is related to the longitudinal character of the follow-up that determines progressive losses of part of the original sample. However, it is worth mentioning that the population sample of the Rio de Janeiro Study is a non-hospitalized sample and has been followed for the last 17 years, constituting the Brazilian cohort within this age range with the longest follow-up to date.</p>
      <p>In conclusion, the maintenance of elevated BP levels from childhood to the young adult life correlated with a more unfavorable profile of cardiovascular risk represented by higher prevalence of arterial hypertension, overweight/obesity, lipid and glycidic alterations as well as the presence of metabolic syndrome in the young adult phase. The findings suggest that the primary prevention measures for cardiovascular risk factors must be initiated in childhood and adolescence.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was partially funded by Faperj.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Erika Maria Gon&#231;alves Campana, from Universidade do Estado do Rio de Janeiro.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
